{"generated": "2026-02-15T22:00:14.430494", "total_unmatched": 123, "total_with_suggestions": 79, "items": [{"id": "novartis_novartis_3a6bd2c0", "company": "novartis", "gong_entity": "Novartis", "gong_parent": "Novartis R&D", "entity_type": "company", "team_size": "100,000", "confidence": "high", "mention_count": 10, "snippet": "This is novartis switchboard", "snippet_date": "2025-12-02", "person_name": "Adam Tomaszewski; Phone Caller #1; Rok Kosir; Samu Melkko; Soumya Badrinath; Stefan Melly", "person_email": "adam.tomaszewski@novartis.com; rok.kosir@novartis.com; samu.melkko@novartis.com; soumya.badrinath@novartis.com; stefan.melly@novartis.com", "internal_name": "Steven Oskui", "internal_email": "steven@biorender.com", "llm_suggested_match": {"manual_node_id": "novartis-rd", "manual_node_name": "Novartis Research & Development", "manual_node_path": "Novartis Research & Development", "confidence": "high", "reasoning": "Exact match to company name - Novartis R&D is the top-level organization in the manual chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c1fba302c3b72a8bdf05535fad909fd1d09bb890f3a12774ace028b5de4aa0fa", "call_id": "2025-12-02_c1fba302c3b7", "call_count": 10, "all_snippets": [{"quote": "This is novartis switchboard", "date": "2025-12-02", "callId": "2025-12-02_c1fba302c3b7", "gongUrl": "https://app.gong.io/call?id=c1fba302c3b72a8bdf05535fad909fd1d09bb890f3a12774ace028b5de4aa0fa", "speakerId": "7995940946197500305", "customerName": "Adam Tomaszewski; Phone Caller #1; Rok Kosir; Samu Melkko; Soumya Badrinath; Stefan Melly", "internalName": "Steven Oskui", "customerEmail": "adam.tomaszewski@novartis.com; rok.kosir@novartis.com; samu.melkko@novartis.com; soumya.badrinath@novartis.com; stefan.melly@novartis.com", "internalEmail": "steven@biorender.com", "sizeMentions": []}, {"quote": "My name's Tim, I support the partnership between novartis and biorender", "date": "2025-09-24", "callId": "2025-09-24_30dd63169c18", "gongUrl": "https://app.gong.io/call?id=30dd63169c18c7a88161d02210279456df2e0cf844c1c4d5bd1bb4c737a45d7e", "speakerId": "4296885493905337777", "customerName": "Aline Piequet; Amrita Bhattacherjee; Anne Sarrabay; Anthony DeLise; Assmann, Donald; Battuja Dugershaw-Kurzer; Battuja Dugershaw-Kurzer; Bellot, Muriel; Benoit Fischer; Berengere Dumotier; Boutwell, Derek; Chen, Tyler; Daniel Bauer; Del Rio, Tony; Dubost, Valerie; Duggan, Erin; Eloise Hudry; Fadela Bouadjemi; Flandre, Thierry; Gabriels, Joseph; Guillemain, Gregory; Herrera, Martha; Hudek, Anna; Hughes, Kevin; Ide, Yudai; Julian Hattler; Julianne Sweeney; Karyn Colman; Klein, Patrick; Koebach, Kyrsten; Kolly, Carine; Kremer, John; Kubek, Katie; Lvov, Anatoli; Magali Jivkov; Maria-1 Vono; Marie-Apolline Seiller; Mathilde Lienard; Michelle Coulson; Michelle Sanchez Guillen; Miller, Natasha; Miranda, Sonia; Morelli, Moran; Morgan, Hannah; Mundo, Eduardo (Ext); Naga, Doha-1 (Ext); Nandan, Tanya; Naven, Russ; Nunes, Jairo; Oberhauser, Nils; Oliver Turner; Ooi, James; PV, Suresh Reddy; Patrovanie, Melissa; Perner, Juliane; Philippe Couttet; Renee Bergeron; Riccardi, Sabrina; Roman, Danielle; Rosner, Elisabeth; Rubic-Schneider, Tina; SENTHILKUMAR PERUMAL KUPPUSAMY; Saravanan, Chandra; Schadt, Heiko; Schwald, Flavio; Smita-1 Jaiswal; Soares Schanoski, Alessandra; Spence, Cheryl; Spence, Fiona; Stull, Robert; Terranova, Remi; Traebert, Martin; Trendelenburg, Christian; Tritto, Elaine-1; Tukov, Francis Fonyuy; Wolak, Eileen; Wong, Valerie; Yadav, Charuta; Yoav Timsit", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "aline.piequet@novartis.com; amrita.bhattacherjee@novartis.com; anne.sarrabay@novartis.com; anthony.delise@novartis.com; donald.assmann@novartis.com; battuja.dugershaw-kurzer@novartis.com; battuja.dugershaw-kurzer@novartis.com; muriel.bellot@novartis.com; benoit.fischer@novartis.com; berengere.dumotier@novartis.com; derek.boutwell@novartis.com; tyler.chen@novartis.com; daniel_manfred.bauer@novartis.com; tony.del_rio@novartis.com; valerie.dubost@novartis.com; erin.duggan@novartis.com; eloise.hudry@novartis.com; fadela.bouadjemi@novartis.com; thierry.flandre@novartis.com; joseph.gabriels@novartis.com; gregory.guillemain@novartis.com; martha.herrera@novartis.com; anna.hudek@novartis.com; kevin.hughes@novartis.com; yudai.ide@novartis.com; julian.hattler@novartis.com; julianne.sweeney@novartis.com; karyn.colman@novartis.com; patrick.klein@novartis.com; kyrsten.koebach@novartis.com; carine.kolly@novartis.com; john.kremer@novartis.com; katie.kubek@novartis.com; anatoli.lvov@novartis.com; magali.jivkov@novartis.com; maria-1.vono@novartis.com; marie-apolline.seiller@novartis.com; mathilde.lienard@novartis.com; michelle.coulson@novartis.com; michelle.sanchez_guillen@novartis.com; natasha.miller@novartis.com; sonia.miranda@novartis.com; moran.morelli@novartis.com; hannah.morgan@novartis.com; eduardo.mundo_ext@novartis.com; doha-1.naga_ext@novartis.com; tanya.nandan@novartis.com; russ.naven@novartis.com; jairo.nunes@novartis.com; nils.oberhauser@novartis.com; oliver.turner@novartis.com; james.ooi@novartis.com; suresh_reddy.pv@novartis.com; melissa.patrovanie@novartis.com; juliane.perner@novartis.com; philippe.couttet@novartis.com; renee.bergeron@novartis.com; sabrina.riccardi@novartis.com; danielle.roman@novartis.com; elisabeth.rosner@novartis.com; tina.rubic@novartis.com; senthilkumar.perumal_kuppusamy@novartis.com; chandra.saravanan@novartis.com; heiko.schadt@novartis.com; flavio.schwald@novartis.com; smita-1.jaiswal@novartis.com; alessandra.soares_schanoski@novartis.com; cheryl.spence@novartis.com; fiona.spence@novartis.com; robert.stull@novartis.com; remi.terranova@novartis.com; martin.traebert@novartis.com; christian.trendelenburg@novartis.com; elaine-1.tritto@novartis.com; francis_fonyuy.tukov@novartis.com; eileen.wolak@novartis.com; valerie.wong@novartis.com; charuta.yadav@novartis.com; yoav.timsit@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I know like Novartis has been working with us to sort of increase our partnership a little bit more", "date": "2025-01-21", "callId": "2025-01-21_3ea6171fde87", "gongUrl": "https://app.gong.io/call?id=3ea6171fde87d6d8d30cafa5803d8de1bda697c4c00d8670add2d33337f8b7cb", "speakerId": "4627937995255245483", "customerName": "Elsie Gonzalez; Elsie Gonzalez", "internalName": "Ross Proudfoot", "customerEmail": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "I've been covering Novartis for a little bit under two years now from the licensing side", "date": "2025-01-10", "callId": "2025-01-10_5d15653f349d", "gongUrl": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "speakerId": "8434859750879709595", "customerName": "Samu Melkko", "internalName": "Ross Proudfoot", "customerEmail": "samu.melkko@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "And also Novart has a website already with pictures, pre made images that we can use and it's allowed to publish and stuff", "date": "2024-12-11", "callId": "2024-12-11_78304dc06cbe", "gongUrl": "https://app.gong.io/call?id=78304dc06cbeb0149df54eacf5dad3dd8df98c7f71f35086019131614db0fab8", "speakerId": "2811105162245034269", "customerName": "Priscila Brandao", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "priscila.brandao@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "Hey, this is Petrillo with Novartis.", "date": "2024-11-26", "callId": "2024-11-26_24d1327cd9ab", "gongUrl": "https://app.gong.io/call?id=24d1327cd9ab97f830da98220f85d425d79383c22d29544088cbc1da5c1f7f87", "speakerId": "6496526823988063502", "customerName": "Battuja Dugershaw-Kurzer; Battuja Dugershaw-Kurzer", "internalName": "Jaden Dankevy", "customerEmail": "battuja.dugershaw-kurzer@novartis.com; battuja.dugershaw-kurzer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "Theres like one section that I think needs to get filled out from Novartis side", "date": "2024-10-25", "callId": "2024-10-25_85b6eae301ab", "gongUrl": "https://app.gong.io/call?id=85b6eae301ab1c999bd0cd8bb0cc094cb12749222a5194b5b76dc17e6a5f0de0", "speakerId": "7527359611771738833", "customerName": "Oswaldo Gonzalez", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "what's important to Novartis?", "date": "2024-10-11", "callId": "2024-10-11_1191f161adba", "gongUrl": "https://app.gong.io/call?id=1191f161adba11553daf88a2140ea4fd20c0064151a0e6a49b18ceca07a18d08", "speakerId": "1665026040121334689", "customerName": "Linda Chin; Oswaldo Gonzalez", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com; oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "So I work with Novartis in the research organization.", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "2765675683771798832", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "I think you can speak a little bit more to like some of the functionalities and uses within Novartis and like how it's fit sort of Novartis' work", "date": "2024-09-17", "callId": "2024-09-17_2770f0ecf6ca", "gongUrl": "https://app.gong.io/call?id=2770f0ecf6caf8b6de4bf776d9b7be8c04d22191130420c7e858481c56dab11e", "speakerId": "1616529226805887646", "customerName": "Ronja Wieboldt", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "ronja.wieboldt@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_basel_1de658f7", "company": "novartis", "gong_entity": "Basel", "gong_parent": "Novartis", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "For Basel, I informed all the colleagues.", "snippet_date": "2025-11-20", "person_name": "Francika Cerkini", "person_email": "francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "basel-switzerland", "manual_node_name": "Basel, Switzerland (Global HQ & Primary R&D Hub)", "manual_node_path": "Novartis Research & Development > Global R&D Sites > Basel, Switzerland (Global HQ & Primary R&D Hub)", "confidence": "high", "reasoning": "Exact location match - Basel is clearly the Swiss headquarters site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=3d31e06c9422a6cd92f02e43d4593513fdd17a489d7de16e24de487bb418b248", "call_id": "2025-11-20_3d31e06c9422", "call_count": 10, "all_snippets": [{"quote": "For Basel, I informed all the colleagues.", "date": "2025-11-20", "callId": "2025-11-20_3d31e06c9422", "gongUrl": "https://app.gong.io/call?id=3d31e06c9422a6cd92f02e43d4593513fdd17a489d7de16e24de487bb418b248", "speakerId": "8749679283669637757", "customerName": "Francika Cerkini", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "we can invite people who are shared on the two lists from Basel and the us", "date": "2025-10-10", "callId": "2025-10-10_a3c2d5b3a13c", "gongUrl": "https://app.gong.io/call?id=a3c2d5b3a13c3cb31735eda09cbfdacf8c2e414dcbf190cd69ad1525ccade394", "speakerId": "8753199157744361751", "customerName": "Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "at least here in Basel, the voice has spread so much at all the levels that at least for the Basel side", "date": "2025-10-07", "callId": "2025-10-07_a6f86cbf1fea", "gongUrl": "https://app.gong.io/call?id=a6f86cbf1feaf33da1cd5f989aff6139470e5f25a4903583ebe774bc84bde900", "speakerId": "2567550711970751141", "customerName": "Francika Cerkini; Francika Cerkini; Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; francika.cerkini@novartis.com; giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "All Basel actually all the same.", "date": "2025-09-29", "callId": "2025-09-29_4f3809a6eeb1", "gongUrl": "https://app.gong.io/call?id=4f3809a6eeb16d33802e0a61d72958762ff9def0bf8be9122d160cf46e88e66a", "speakerId": "926768956698952878", "customerName": "Anderhub, Simon; Fabienne Schuetz; Frederik Petri; Gwennaelle Monnot", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova; Tim Fung", "customerEmail": "simon.anderhub@novartis.com; fabienne.schuetz@novartis.com; frederik.petri@novartis.com; gwennaelle.monnot@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I think there are some within Basel on that license as well", "date": "2025-08-27", "callId": "2025-08-27_ae4bb8bcbac3", "gongUrl": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "speakerId": "2604523071425011415", "customerName": "Robert Szabo", "internalName": "Ross Proudfoot", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "Ah, Basel in Switzerland", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}, {"quote": "I think that separates out us and Basel", "date": "2025-04-22", "callId": "2025-04-22_eadcc63b7b0b", "gongUrl": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "speakerId": "1927124463874826460", "customerName": "Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "It's the locations are mostly in Basel in Switzerland and in Cambridge, you know, Massachusetts", "date": "2025-01-10", "callId": "2025-01-10_5d15653f349d", "gongUrl": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "speakerId": "233530352534476423", "customerName": "Samu Melkko", "internalName": "Ross Proudfoot", "customerEmail": "samu.melkko@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "but that's what, strange that she's in Basel", "date": "2024-03-08", "callId": "2024-03-08_bd30543bbdc0", "gongUrl": "https://app.gong.io/call?id=bd30543bbdc03f24e0b14c21bbc65a1a96456cf48929ca9d465dfb86ba447098", "speakerId": "4775345041432867371", "customerName": "Linda Chin", "internalName": "Ross Proudfoot", "customerEmail": "linda.chin@novartis.com; carlos-2.lopez_ext@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "So there are basically two teams, one in vegas in Slovenia and one in basil in Switzerland.", "date": "2024-02-20", "callId": "2024-02-20_56aed2d86447", "gongUrl": "https://app.gong.io/call?id=56aed2d864477a227556448ee58e819d5ac362ae15fd23445426b1f60e093b93", "speakerId": "4231809808949283905", "customerName": "Davor Obradovic", "internalName": "Ross Proudfoot", "customerEmail": "davor.obradovic@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cambridge_eb140c70", "company": "novartis", "gong_entity": "Cambridge", "gong_parent": "Novartis", "entity_type": "site", "team_size": "80", "confidence": "high", "mention_count": 9, "snippet": "And then same with the cambridge site now as well.", "snippet_date": "2025-11-20", "person_name": "Francika Cerkini", "person_email": "francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "cambridge-ma", "manual_node_name": "Cambridge, MA, USA", "manual_node_path": "Novartis Research & Development > Global R&D Sites > Cambridge, MA, USA", "confidence": "high", "reasoning": "Exact location match - Cambridge refers to the Massachusetts R&D site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=3d31e06c9422a6cd92f02e43d4593513fdd17a489d7de16e24de487bb418b248", "call_id": "2025-11-20_3d31e06c9422", "call_count": 9, "all_snippets": [{"quote": "And then same with the cambridge site now as well.", "date": "2025-11-20", "callId": "2025-11-20_3d31e06c9422", "gongUrl": "https://app.gong.io/call?id=3d31e06c9422a6cd92f02e43d4593513fdd17a489d7de16e24de487bb418b248", "speakerId": "2483660033910624640", "customerName": "Francika Cerkini", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "So, yeah, I'm in cambridge", "date": "2025-10-07", "callId": "2025-10-07_a6f86cbf1fea", "gongUrl": "https://app.gong.io/call?id=a6f86cbf1feaf33da1cd5f989aff6139470e5f25a4903583ebe774bc84bde900", "speakerId": "1491609823502661415", "customerName": "Francika Cerkini; Francika Cerkini; Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; francika.cerkini@novartis.com; giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "It sounds like they might bring cambridge on to that meeting as well.", "date": "2025-09-26", "callId": "2025-09-26_cbfda20d68ec", "gongUrl": "https://app.gong.io/call?id=cbfda20d68ec271c79e983fc73fa5ff628ad2fa284e674a2b05ec97ef8fcf38d", "speakerId": "8910611653600014103", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "My initial thought was just to invite whatever the ankh cambridge users are", "date": "2025-04-22", "callId": "2025-04-22_eadcc63b7b0b", "gongUrl": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "speakerId": "8432339154031794193", "customerName": "Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "It's the locations are mostly in Basel in Switzerland and in Cambridge, you know, Massachusetts", "date": "2025-01-10", "callId": "2025-01-10_5d15653f349d", "gongUrl": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "speakerId": "233530352534476423", "customerName": "Samu Melkko", "internalName": "Ross Proudfoot", "customerEmail": "samu.melkko@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "Someone in cambridge tried it and didn't work", "date": "2024-03-08", "callId": "2024-03-08_bd30543bbdc0", "gongUrl": "https://app.gong.io/call?id=bd30543bbdc03f24e0b14c21bbc65a1a96456cf48929ca9d465dfb86ba447098", "speakerId": "4775345041432867371", "customerName": "Linda Chin", "internalName": "Ross Proudfoot", "customerEmail": "linda.chin@novartis.com; carlos-2.lopez_ext@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "there's 80 scientists here in cambridge in our group", "date": "2023-06-21", "callId": "2023-06-21_3d6910a4f003", "gongUrl": "https://app.gong.io/call?id=3d6910a4f00319fb274790f8b9291ba4029ac504b15142592b859aef6dd89549", "speakerId": "6458267621969453639", "customerName": "Charles Banos", "internalName": "Ross Proudfoot", "customerEmail": "charles.banos@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": [{"value": "80", "snippetIndex": 6, "source": {"callDate": "2023-06-21", "customerName": "Charles Banos"}}]}, {"quote": "We typically, we have some\u2026 extended meeting with quite many people typically with cambridge. So we collaborate a lot with cambridge.", "date": "2023-05-30", "callId": "2023-05-30_96a758c8b4f2", "gongUrl": "https://app.gong.io/call?id=96a758c8b4f2aeab547c13fb5c99761136670f85080c507fd6a6f5b837efabf0", "speakerId": "4756458008587114223", "customerName": "Agostino Cirillo", "internalName": "Ross Proudfoot", "customerEmail": "agostino.cirillo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "So in cambridge, Massachusetts. That's the headquarters for niber", "date": "2023-05-15", "callId": "2023-05-15_834463ba859f", "gongUrl": "https://app.gong.io/call?id=834463ba859fdc25932eb4580c1c5cca1d1907b5eccc809914809949a9749922", "speakerId": "3141364032382923138", "customerName": "Nadia Hassounah", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "nadia.hassounah@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_nibr_3df852e7", "company": "novartis", "gong_entity": "NIBR", "gong_parent": "Novartis", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 6, "snippet": "everyone within nibr or BR were able to sort of request licensing", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": {"manual_node_id": "nibr-cambridge", "manual_node_name": "Novartis Institutes for BioMedical Research (NIBR) - Cambridge, MA", "manual_node_path": "Novartis Research & Development > Biomedical Research > Novartis Institutes for BioMedical Research (NIBR) - Cambridge, MA", "confidence": "high", "reasoning": "Perfect acronym match - NIBR expands to Novartis Institutes for BioMedical Research"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 6, "all_snippets": [{"quote": "everyone within nibr or BR were able to sort of request licensing", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "7027995544158346041", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "a lot of people at Novartis are researchers within like the NIBR arm who have access to BioRender", "date": "2025-01-29", "callId": "2025-01-29_63e8611ee363", "gongUrl": "https://app.gong.io/call?id=63e8611ee363334b7f259adbcfd64b8e662b0e41438c3f1b48a85ebf74f7fb40", "speakerId": "2677693601495068856", "customerName": "Dennis Cerrato", "internalName": "Jaden Dankevy", "customerEmail": "dennis.cerrato@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "but you wouldn't be actually be a part of NIBR. Would you the NIBR?", "date": "2025-01-13", "callId": "2025-01-13_6a9afd79e80c", "gongUrl": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "speakerId": "2887880731559812773", "customerName": "Robert Szabo", "internalName": "Jaden Dankevy", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "BioRender is mostly used by NIBR or Scientific Research Center", "date": "2025-01-10", "callId": "2025-01-10_e4f1c39631f6", "gongUrl": "https://app.gong.io/call?id=e4f1c39631f6aef0211c0fd45bedf808cac4484f27e8c9b13510b84bdd8e54bf", "speakerId": "6675217776239111794", "customerName": "Andrea Lopez; Andrea Lopez", "internalName": "Jaden Dankevy", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "I think right now it's nibr", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "4601677825082276171", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "we work with R and D arm of the Novartis, which you guys probably are working predominantly with them called nyber, which used to be called nyber", "date": "2024-03-27", "callId": "2024-03-27_855f773b00e5", "gongUrl": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "speakerId": "171743836081310569", "customerName": "Prateek Tripathi", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "prateek.tripathi@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_technical_research_and_development_d32b6fbf", "company": "novartis", "gong_entity": "Technical Research and Development", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "If you guys do move to longer term biorender licensing across your TRD functions.", "snippet_date": "2025-09-29", "person_name": "Anderhub, Simon; Fabienne Schuetz; Frederik Petri; Gwennaelle Monnot", "person_email": "simon.anderhub@novartis.com; fabienne.schuetz@novartis.com; frederik.petri@novartis.com; gwennaelle.monnot@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova; Tim Fung", "internal_email": "ross@biorender.com; sofiya.m@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences", "manual_node_name": "Pharmaceutical Sciences (Technical R&D)", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D)", "confidence": "high", "reasoning": "Exact semantic match - Technical R&D is explicitly noted as Pharmaceutical Sciences division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4f3809a6eeb16d33802e0a61d72958762ff9def0bf8be9122d160cf46e88e66a", "call_id": "2025-09-29_4f3809a6eeb1", "call_count": 10, "all_snippets": [{"quote": "If you guys do move to longer term biorender licensing across your TRD functions.", "date": "2025-09-29", "callId": "2025-09-29_4f3809a6eeb1", "gongUrl": "https://app.gong.io/call?id=4f3809a6eeb16d33802e0a61d72958762ff9def0bf8be9122d160cf46e88e66a", "speakerId": "5142361611882698808", "customerName": "Anderhub, Simon; Fabienne Schuetz; Frederik Petri; Gwennaelle Monnot", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova; Tim Fung", "customerEmail": "simon.anderhub@novartis.com; fabienne.schuetz@novartis.com; frederik.petri@novartis.com; gwennaelle.monnot@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I'm part of TRD and like TRD generally is not really using that biorender because it's like more like a conformational department", "date": "2025-08-27", "callId": "2025-08-27_ae4bb8bcbac3", "gongUrl": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "speakerId": "7015016855544201927", "customerName": "Robert Szabo", "internalName": "Ross Proudfoot", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "she did does not have the TRD people on it", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "2567351405035696877", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "We just had, we've, had a trd team that's been looking to get licensing through software one since like last October and November.", "date": "2025-02-07", "callId": "2025-02-07_f780f2fabe76", "gongUrl": "https://app.gong.io/call?id=f780f2fabe76e4160207b613012ddce01cbb414b99143d7a2643e28aa733d032", "speakerId": "7871013341411051570", "customerName": "", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I'm i'm trd. So i'm technical research and development.", "date": "2025-01-13", "callId": "2025-01-13_6a9afd79e80c", "gongUrl": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "speakerId": "7132722879719429782", "customerName": "Robert Szabo", "internalName": "Jaden Dankevy", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "The only other thing adam is we do have a license in trd as well.", "date": "2024-12-13", "callId": "2024-12-13_dd2cf5d63456", "gongUrl": "https://app.gong.io/call?id=dd2cf5d634563379a31be9c05e8ea3e182634d50882d788f75c78d99c45146c2", "speakerId": "8037355796635810381", "customerName": "Oswaldo Gonzalez", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I think primarily it was biomedical research but we do have like a TRD license as well now", "date": "2024-09-06", "callId": "2024-09-06_169896fe10d3", "gongUrl": "https://app.gong.io/call?id=169896fe10d3c8d7ef75c09e16265eb99e34ccc5d53a6ea03ba7c235f1c2ea02", "speakerId": "4790105840873293174", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "this is BR, so biological research or is this also TRD which is technical research and development", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "910876744940341148", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "There is a TRD which is technical R and D", "date": "2024-03-27", "callId": "2024-03-27_855f773b00e5", "gongUrl": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "speakerId": "171743836081310569", "customerName": "Prateek Tripathi", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "prateek.tripathi@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "I was just curious about like, you know, on the TRD side, like if there are other people that would also benefit from using bar under.", "date": "2023-08-24", "callId": "2023-08-24_e351be9a4480", "gongUrl": "https://app.gong.io/call?id=e351be9a448049555315bab4bf6624bc623593f2ec8f8eb556ff5074149b57c7", "speakerId": "7315095713442143945", "customerName": "", "internalName": "Tim Fung", "customerEmail": "marianne.goodwin@novartis.com; holly.appleton@novartis.com; chunping.qiao@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_preclinical_safety_4bd4a336", "company": "novartis", "gong_entity": "Preclinical Safety", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "but maybe you have already spoken with some people in PCS?", "snippet_date": "2025-12-11", "person_name": "Silvana Libertini", "person_email": "silvana.libertini@novartis.com", "internal_name": "Sofiya Medvezhonkova", "internal_email": "sofiya.m@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=5d73fec56ebed7a710c04ce2c7313e7469ee420b186a976127b037fa5876563c", "call_id": "2025-12-11_5d73fec56ebe", "call_count": 10, "all_snippets": [{"quote": "but maybe you have already spoken with some people in PCS?", "date": "2025-12-11", "callId": "2025-12-11_5d73fec56ebe", "gongUrl": "https://app.gong.io/call?id=5d73fec56ebed7a710c04ce2c7313e7469ee420b186a976127b037fa5876563c", "speakerId": "2649079224699958541", "customerName": "Silvana Libertini", "internalName": "Sofiya Medvezhonkova", "customerEmail": "silvana.libertini@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "There's PCS, which is preclinical safety", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "540529526687666601", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "But I have been in touch with somebody in PCS, tuya, who helped us put together", "date": "2025-11-05", "callId": "2025-11-05_cebf2186536f", "gongUrl": "https://app.gong.io/call?id=cebf2186536fb0a794dd7ed70022fed95b6107edc9abf012ee6cc8b981a91bc9", "speakerId": "2984491289675242830", "customerName": "Renee Bergeron", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "renee.bergeron@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "Julia, yes, from PCS", "date": "2025-10-07", "callId": "2025-10-07_a77c81c9272f", "gongUrl": "https://app.gong.io/call?id=a77c81c9272f4965546cd20705c82ef2ccf8ed05a6c0e0742b0775d9717a404c", "speakerId": "1614145282518275477", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com; ludivine.flotte@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "Yeah, PCS and TM together on exactly.", "date": "2025-09-26", "callId": "2025-09-26_cbfda20d68ec", "gongUrl": "https://app.gong.io/call?id=cbfda20d68ec271c79e983fc73fa5ff628ad2fa284e674a2b05ec97ef8fcf38d", "speakerId": "376604606706690514", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I talked to the lady from PCS yesterday because she contacted me and she said, oh, she wants to join the pilot", "date": "2025-09-18", "callId": "2025-09-18_9e103181fbb6", "gongUrl": "https://app.gong.io/call?id=9e103181fbb6334420894f40a9b0056365e997f6c790f775a3d2d2dc8205168b", "speakerId": "5338325165650498457", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I'm checking with the PKS PCS and cis guys. So those are all from translational medicine currently", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "2567351405035696877", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "Don't, we have a couple of people in pcs right now, there is, I think there's about three.", "date": "2025-01-31", "callId": "2025-01-31_ac67da9a8be4", "gongUrl": "https://app.gong.io/call?id=ac67da9a8be462fa07ab7b83218d3e03fb6403757cdf923089f38aec0f2ec713", "speakerId": "6524210929564734254", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "My colleague Ross also informed me though that he may be in contact with a woman named Hannah Morgan within PCS.", "date": "2025-01-28", "callId": "2025-01-28_590515e45aff", "gongUrl": "https://app.gong.io/call?id=590515e45affc7a044cf18406ab5caa7c68908aaad4ce2564dc7078e4f417f64", "speakerId": "4709327903517203486", "customerName": "Battuja Dugershaw-Kurzer; Battuja Dugershaw-Kurzer", "internalName": "Jaden Dankevy", "customerEmail": "battuja.dugershaw-kurzer@novartis.com; battuja.dugershaw-kurzer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "However, coming back to our main goal to have this kind of demo and distributing these kind of trials within PCS, I'm definitely working on it.", "date": "2024-11-26", "callId": "2024-11-26_24d1327cd9ab", "gongUrl": "https://app.gong.io/call?id=24d1327cd9ab97f830da98220f85d425d79383c22d29544088cbc1da5c1f7f87", "speakerId": "3235805505651984322", "customerName": "Battuja Dugershaw-Kurzer; Battuja Dugershaw-Kurzer", "internalName": "Jaden Dankevy", "customerEmail": "battuja.dugershaw-kurzer@novartis.com; battuja.dugershaw-kurzer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_oncology_4a58f37b", "company": "novartis", "gong_entity": "Oncology", "gong_parent": "Biomedical Research", "entity_type": "therapeutic_area", "team_size": "50", "confidence": "high", "mention_count": 10, "snippet": "Biorender is being used at various departments within novartis including oncology, immunology", "snippet_date": "2025-12-15", "person_name": "Oliver Pohl", "person_email": "oliver.pohl@novartis.com", "internal_name": "Sofiya Medvezhonkova", "internal_email": "sofiya.m@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "Novartis Research & Development > Biomedical Research > Oncology Research", "confidence": "high", "reasoning": "Strong match - Oncology entity maps to Oncology Research therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=af4b5d9111d778c95d0f4952a90fdfcfb6da57621b0ca4f70be43cc412c3d8da", "call_id": "2025-12-15_af4b5d9111d7", "call_count": 10, "all_snippets": [{"quote": "Biorender is being used at various departments within novartis including oncology, immunology", "date": "2025-12-15", "callId": "2025-12-15_af4b5d9111d7", "gongUrl": "https://app.gong.io/call?id=af4b5d9111d778c95d0f4952a90fdfcfb6da57621b0ca4f70be43cc412c3d8da", "speakerId": "8860790880597591384", "customerName": "Oliver Pohl", "internalName": "Sofiya Medvezhonkova", "customerEmail": "oliver.pohl@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "So oncology, their immunology just come up top of mind for me", "date": "2025-12-12", "callId": "2025-12-12_76ea16c091b3", "gongUrl": "https://app.gong.io/call?id=76ea16c091b3b934aa24e7c1c700937bdd70675692b817ac96a17e5cb6f61fb6", "speakerId": "3200669453604377621", "customerName": "Julius Decano", "internalName": "Sofiya Medvezhonkova", "customerEmail": "julius.decano@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "7027995544158346041", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "So I help support, the teams at novartis have supported disease area X as well as oncology as well", "date": "2025-11-24", "callId": "2025-11-24_2aa051af661f", "gongUrl": "https://app.gong.io/call?id=2aa051af661fd3a73bd3cc18c316143f68875d79dbbfb4f2cfce553e10f3cbb6", "speakerId": "3019153258745807129", "customerName": "Amitabh Nimonkar", "internalName": "Sofiya Medvezhonkova", "customerEmail": "amitabh.nimonkar@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "Were there any thoughts of like more broadly letting people in oncology know that they have access.", "date": "2025-11-20", "callId": "2025-11-20_3d31e06c9422", "gongUrl": "https://app.gong.io/call?id=3d31e06c9422a6cd92f02e43d4593513fdd17a489d7de16e24de487bb418b248", "speakerId": "2483660033910624640", "customerName": "Francika Cerkini", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "oncology is now brought on the same licensing that you guys have as well as Dax", "date": "2025-11-11", "callId": "2025-11-11_f7c2ee51d20a", "gongUrl": "https://app.gong.io/call?id=f7c2ee51d20a106cf6751a506ff5556d0c12467a8559015818ae581fcab7c787", "speakerId": "7239136083605626808", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "What we can also do at the same time is make sure that their portal that the oncology portal page remains hidden.", "date": "2025-10-10", "callId": "2025-10-10_a3c2d5b3a13c", "gongUrl": "https://app.gong.io/call?id=a3c2d5b3a13c3cb31735eda09cbfdacf8c2e414dcbf190cd69ad1525ccade394", "speakerId": "8753199157744361751", "customerName": "Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "work something that's better suited for oncology biomedical research", "date": "2025-10-07", "callId": "2025-10-07_a6f86cbf1fea", "gongUrl": "https://app.gong.io/call?id=a6f86cbf1feaf33da1cd5f989aff6139470e5f25a4903583ebe774bc84bde900", "speakerId": "6311946371869784712", "customerName": "Francika Cerkini; Francika Cerkini; Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; francika.cerkini@novartis.com; giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "So, we're from oncology.", "date": "2025-08-27", "callId": "2025-08-27_3e469abe4357", "gongUrl": "https://app.gong.io/call?id=3e469abe43575255dd7d7808adfae50c406e65c802c4e4a1b574f465ba1f3bbe", "speakerId": "2440457383943324624", "customerName": "Ciric To", "internalName": "Sofiya Medvezhonkova", "customerEmail": "ciric.to@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "Yeah, I'm a part of oncology", "date": "2025-08-20", "callId": "2025-08-20_7a90b6a99019", "gongUrl": "https://app.gong.io/call?id=7a90b6a99019e8182e7cffcf016d2b2d4fdf7d265ac8b704feaa8823d9f34494", "speakerId": "9086115162157472282", "customerName": "Drasti Kanakia; Drasti Kanakia", "internalName": "Sofiya Medvezhonkova", "customerEmail": "drasti.kanakia@novartis.com; drasti.kanakia@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}]}, {"id": "novartis_oncology_basel_6eda86ae", "company": "novartis", "gong_entity": "Oncology Basel", "gong_parent": "Oncology", "entity_type": "site_department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So that's with them\u2026 with giuseppe, I guess, but that's only oncology Basel because they separated it somehow from the S", "snippet_date": "2025-09-26", "person_name": "Stefan Melly", "person_email": "stefan.melly@novartis.com; adam.tomaszewski@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "Novartis Research & Development > Biomedical Research > Oncology Research", "confidence": "medium", "reasoning": "Partial match - represents Oncology function at Basel site, but no specific Basel oncology node exists"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cbfda20d68ec271c79e983fc73fa5ff628ad2fa284e674a2b05ec97ef8fcf38d", "call_id": "2025-09-26_cbfda20d68ec", "call_count": 1, "all_snippets": [{"quote": "So that's with them\u2026 with giuseppe, I guess, but that's only oncology Basel because they separated it somehow from the S", "date": "2025-09-26", "callId": "2025-09-26_cbfda20d68ec", "gongUrl": "https://app.gong.io/call?id=cbfda20d68ec271c79e983fc73fa5ff628ad2fa284e674a2b05ec97ef8fcf38d", "speakerId": "376604606706690514", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cardiovascular,_renal_&_metabolism_(cvm)_cdc42eed", "company": "novartis", "gong_entity": "Cardiovascular, Renal & Metabolism (CVM)", "gong_parent": "Biomedical Research", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "I'm, in CVM, cardiovascular and metabolic diseases.", "snippet_date": "2025-11-24", "person_name": "Amitabh Nimonkar", "person_email": "amitabh.nimonkar@novartis.com", "internal_name": "Sofiya Medvezhonkova", "internal_email": "sofiya.m@biorender.com", "llm_suggested_match": {"manual_node_id": "cardiovascular-renal-metabolic", "manual_node_name": "Cardiovascular, Renal & Metabolic Diseases", "manual_node_path": "Novartis Research & Development > Biomedical Research > Cardiovascular, Renal & Metabolic Diseases", "confidence": "high", "reasoning": "Exact match - entity is the full name with acronym CVM matching the manual node 'Cardiovascular, Renal & Metabolic Diseases'"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2aa051af661fd3a73bd3cc18c316143f68875d79dbbfb4f2cfce553e10f3cbb6", "call_id": "2025-11-24_2aa051af661f", "call_count": 10, "all_snippets": [{"quote": "I'm, in CVM, cardiovascular and metabolic diseases.", "date": "2025-11-24", "callId": "2025-11-24_2aa051af661f", "gongUrl": "https://app.gong.io/call?id=2aa051af661fd3a73bd3cc18c316143f68875d79dbbfb4f2cfce553e10f3cbb6", "speakerId": "5279424651120015458", "customerName": "Amitabh Nimonkar", "internalName": "Sofiya Medvezhonkova", "customerEmail": "amitabh.nimonkar@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "I have no idea what like CVM and ioh and the other groups are doing", "date": "2025-04-22", "callId": "2025-04-22_eadcc63b7b0b", "gongUrl": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "speakerId": "8432339154031794193", "customerName": "Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I'm a postdoctoral fellow at novars, okay. And in CVM cardiovascular disease", "date": "2025-02-20", "callId": "2025-02-20_8d3641b3d9a7", "gongUrl": "https://app.gong.io/call?id=8d3641b3d9a76b9da66c9091c7f17518f7030ea29ec521978f378e72feeb193d", "speakerId": "6329354995973001406", "customerName": "Hayley Kim; Hayley Kim", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "hayley.kim@novartis.com; hayley.kim@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "So, I mean, right now, I'm in CVM which is the cardiovascular and metabolic disease group.", "date": "2025-01-10", "callId": "2025-01-10_9e7222a482fb", "gongUrl": "https://app.gong.io/call?id=9e7222a482fb050fd6ee6838be736f9284bf15a1a14b3229206f6f355fc1ace8", "speakerId": "766346542485550655", "customerName": "Ivan Barrera", "internalName": "Jaden Dankevy", "customerEmail": "ivan.barrera@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "CVM only has, you know, one or two licenses", "date": "2024-11-22", "callId": "2024-11-22_e20004be2828", "gongUrl": "https://app.gong.io/call?id=e20004be28286bd7f40b3866229d865fe589e086a513cb67a12caa07e4981cdf", "speakerId": "4856232018215526498", "customerName": "Linda Chin; Oswaldo Gonzalez", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com; oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "So the four pillars of the company are cardiovascular, neuroscience, oncology", "date": "2025-01-13", "callId": "2025-01-13_d36981559ab1", "gongUrl": "https://app.gong.io/call?id=d36981559ab16fa615cc63c28f36976d16eb2cc6b4793cd506b1c5d2c5e88c1e", "speakerId": "7927283921806677683", "customerName": "Magali Saint-Geniez; Magali Saint-Geniez", "internalName": "Ross Proudfoot", "customerEmail": "magali.saint-geniez@novartis.com; magali.saint-geniez@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "like the different disease areas like, you know, oncology, immunology, neuroscience, and so on cardiovascular", "date": "2025-01-10", "callId": "2025-01-10_5d15653f349d", "gongUrl": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "speakerId": "233530352534476423", "customerName": "Samu Melkko", "internalName": "Ross Proudfoot", "customerEmail": "samu.melkko@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "But yes, I do work, you know, very closely with, like, disease areas, like immuno oncology and cardiovascular and all of them as well", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "2765675683771798832", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "I'm the head of operations for cardiovascular and metabolic diseases", "date": "2024-03-01", "callId": "2024-03-01_7b31b87ac1bd", "gongUrl": "https://app.gong.io/call?id=7b31b87ac1bd97c480914d2a3847bec6652478931e5b2f06276fa50103a7fb6e", "speakerId": "5644665664633752396", "customerName": "Adam; Carlos-2 Lopez; Linda Chin; Marion Wiesmann; Petra Simic; Stefan Melly", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; carlos-2.lopez_ext@novartis.com; linda.chin@novartis.com; marion.wiesmann@novartis.com; petra.simic@novartis.com; stefan.melly@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}, {"quote": "the entire CVM team, the entire CVM, we're more or less like 150 plus", "date": "2025-12-12", "callId": "2025-12-12_76ea16c091b3", "gongUrl": "https://app.gong.io/call?id=76ea16c091b3b934aa24e7c1c700937bdd70675692b817ac96a17e5cb6f61fb6", "speakerId": "7482502800940294767", "customerName": "Julius Decano", "internalName": "Sofiya Medvezhonkova", "customerEmail": "julius.decano@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cvms_c8941cf9", "company": "novartis", "gong_entity": "CVMS", "gong_parent": "Cardiovascular, Renal & Metabolism (CVM)", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "I think we have three people in cvms using the bio render", "snippet_date": "2025-11-04", "person_name": "Hayley Kim; Ilaria Russo", "person_email": "hayley.kim@novartis.com; ilaria.russo@novartis.com", "internal_name": "Tim Fung", "internal_email": "tim@biorender.com", "llm_suggested_match": {"manual_node_id": "cardiovascular-renal-metabolic", "manual_node_name": "Cardiovascular, Renal & Metabolic Diseases", "manual_node_path": "Novartis Research & Development > Biomedical Research > Cardiovascular, Renal & Metabolic Diseases", "confidence": "medium", "reasoning": "Likely acronym match - CVMS appears to be a variant of CVM (Cardiovascular, Renal & Metabolic) with an additional 'S', possibly for 'Sciences' or similar"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b71d8db9b67f4b894bc3685c432873050d33fbddcc16619c2ff4958d646d8100", "call_id": "2025-11-04_b71d8db9b67f", "call_count": 1, "all_snippets": [{"quote": "I think we have three people in cvms using the bio render", "date": "2025-11-04", "callId": "2025-11-04_b71d8db9b67f", "gongUrl": "https://app.gong.io/call?id=b71d8db9b67f4b894bc3685c432873050d33fbddcc16619c2ff4958d646d8100", "speakerId": "386415180904184865", "customerName": "Hayley Kim; Ilaria Russo", "internalName": "Tim Fung", "customerEmail": "hayley.kim@novartis.com; ilaria.russo@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_neuroinflammation_abd9713b", "company": "novartis", "gong_entity": "Neuroinflammation", "gong_parent": "Neuroscience", "entity_type": "sub_team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then under him there's neurodegeneration, neuroinflammation, and neuromuscular", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": {"manual_node_id": "neuroimmunology", "manual_node_name": "Neuroimmunology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Neuroscience > Neuroimmunology", "confidence": "medium", "reasoning": "Semantic match - 'Neuroinflammation' is closely related to 'Neuroimmunology' as both deal with immune/inflammatory processes in the nervous system"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 1, "all_snippets": [{"quote": "And then under him there's neurodegeneration, neuroinflammation, and neuromuscular", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "540529526687666601", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}]}, {"id": "novartis_neuromuscular_3097848c", "company": "novartis", "gong_entity": "Neuromuscular", "gong_parent": "Neuroscience", "entity_type": "sub_team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then under him there's neurodegeneration, neuroinflammation, and neuromuscular", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 1, "all_snippets": [{"quote": "And then under him there's neurodegeneration, neuroinflammation, and neuromuscular", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "540529526687666601", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}]}, {"id": "novartis_immuno_oncology_60228528", "company": "novartis", "gong_entity": "Immuno Oncology", "gong_parent": "Biomedical Research", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "immuno, oncology, I mean, I lead as Anne does, I lead cell and gene therapy group", "snippet_date": "2025-07-03", "person_name": "Jennifer Brogdon", "person_email": "jennifer.brogdon@novartis.com", "internal_name": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "internal_email": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "Novartis Research & Development > Biomedical Research > Oncology Research", "confidence": "medium", "reasoning": "Partial match - 'Immuno Oncology' relates to oncology research, though it's specifically the immunotherapy aspect of oncology which isn't separately represented"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "call_id": "2025-07-03_ef14d537dd56", "call_count": 3, "all_snippets": [{"quote": "immuno, oncology, I mean, I lead as Anne does, I lead cell and gene therapy group", "date": "2025-07-03", "callId": "2025-07-03_ef14d537dd56", "gongUrl": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "speakerId": "1484652332788337034", "customerName": "Jennifer Brogdon", "internalName": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "customerEmail": "jennifer.brogdon@novartis.com", "internalEmail": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "There's two separate immuno oncology licenses prior.", "date": "2025-01-09", "callId": "2025-01-09_7041dfd1f4da", "gongUrl": "https://app.gong.io/call?id=7041dfd1f4dad46a9177bf790dc9f0a5c058feaae1ad1a7bdb46dd049aa049aa", "speakerId": "8738581762514636973", "customerName": "Deborah Castelletti; Deborah Castelletti", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "deborah.castelletti@novartis.com; deborah.castelletti@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "But yes, I do work, you know, very closely with, like, disease areas, like immuno oncology and cardiovascular and all of them as well", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "2765675683771798832", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biologics_9329fd6e", "company": "novartis", "gong_entity": "Biologics", "gong_parent": "Biomedical Research", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "I know immunology and biologics kind of got flagged to us", "snippet_date": "2025-04-16", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development", "manual_node_name": "Biologics Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development", "confidence": "high", "reasoning": "Strong match - 'Biologics' directly corresponds to 'Biologics Development' department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "call_id": "2025-04-16_0ed32b9f3917", "call_count": 3, "all_snippets": [{"quote": "I know immunology and biologics kind of got flagged to us", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "8312379094350391382", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "Biologics is a line function", "date": "2025-01-13", "callId": "2025-01-13_d36981559ab1", "gongUrl": "https://app.gong.io/call?id=d36981559ab16fa615cc63c28f36976d16eb2cc6b4793cd506b1c5d2c5e88c1e", "speakerId": "7927283921806677683", "customerName": "Magali Saint-Geniez; Magali Saint-Geniez", "internalName": "Ross Proudfoot", "customerEmail": "magali.saint-geniez@novartis.com; magali.saint-geniez@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "And then there are platforms like Biologics, Lomel, Kuwait, Screening things like this", "date": "2025-01-10", "callId": "2025-01-10_5d15653f349d", "gongUrl": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "speakerId": "233530352534476423", "customerName": "Samu Melkko", "internalName": "Ross Proudfoot", "customerEmail": "samu.melkko@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biologic_group_a96e8b64", "company": "novartis", "gong_entity": "Biologic Group", "gong_parent": "Biologics", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 2, "snippet": "There's a biologic group, a Gene therapies group", "snippet_date": "2024-05-17", "person_name": "Linda Chin", "person_email": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development", "manual_node_name": "Biologics Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development", "confidence": "high", "reasoning": "Strong match - 'Biologic Group' is essentially the same as 'Biologics Development' department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "call_id": "2024-05-17_560cfd6973cd", "call_count": 2, "all_snippets": [{"quote": "There's a biologic group, a Gene therapies group", "date": "2024-05-17", "callId": "2024-05-17_560cfd6973cd", "gongUrl": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "speakerId": "3977144156519309438", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "March tenth 2025 but I think that's that would be a biologic group", "date": "2024-05-10", "callId": "2024-05-10_859d7d55b37d", "gongUrl": "https://app.gong.io/call?id=859d7d55b37dc640b48f44ef0a7937490a477dd08b26e0ae81feb2c875fa9cda", "speakerId": "7419921050103242439", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_gene_therapy_9d3e3f98", "company": "novartis", "gong_entity": "Gene Therapy", "gong_parent": "Biomedical Research", "entity_type": "therapeutic_area", "team_size": null, "confidence": "medium", "mention_count": 2, "snippet": "I think our other one's gene therapy", "snippet_date": "2025-08-27", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "gene-therapy-platform", "manual_node_name": "Gene Therapy Platform", "manual_node_path": "Novartis Research & Development > Platform Technologies & Capabilities > Gene Therapy Platform", "confidence": "high", "reasoning": "Strong match - 'Gene Therapy' directly corresponds to 'Gene Therapy Platform' department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "call_id": "2025-08-27_ae4bb8bcbac3", "call_count": 2, "all_snippets": [{"quote": "I think our other one's gene therapy", "date": "2025-08-27", "callId": "2025-08-27_ae4bb8bcbac3", "gongUrl": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "speakerId": "2604523071425011415", "customerName": "Robert Szabo", "internalName": "Ross Proudfoot", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "are there others at Gene therapy that need that would find value in?", "date": "2023-08-24", "callId": "2023-08-24_e351be9a4480", "gongUrl": "https://app.gong.io/call?id=e351be9a448049555315bab4bf6624bc623593f2ec8f8eb556ff5074149b57c7", "speakerId": "7315095713442143945", "customerName": "", "internalName": "Tim Fung", "customerEmail": "marianne.goodwin@novartis.com; holly.appleton@novartis.com; chunping.qiao@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_brc_a9af21d3", "company": "novartis", "gong_entity": "BRC", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 8, "snippet": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "high", "reasoning": "BRC is a clear acronym for Biomedical Research Center/Biomedical Research, which matches the Biomedical Research division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 8, "all_snippets": [{"quote": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "7027995544158346041", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "we have 400 associates total, and these are divided in 10", "date": "2025-12-02", "callId": "2025-12-02_41d9b0c0e016", "gongUrl": "https://app.gong.io/call?id=41d9b0c0e016bd8cf0984f2b1d10766c04b0e9409b3f74de5eaaf6482e43f478", "speakerId": "362611694764122637", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "we just onboarded, a few more associates in San Diego. So, like PRC is growing", "date": "2025-11-11", "callId": "2025-11-11_f7c2ee51d20a", "gongUrl": "https://app.gong.io/call?id=f7c2ee51d20a106cf6751a506ff5556d0c12467a8559015818ae581fcab7c787", "speakerId": "4401482907785075564", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "But in terms of the adoption as well, quite solid for all of BRC", "date": "2025-09-16", "callId": "2025-09-16_7fc0c5b16655", "gongUrl": "https://app.gong.io/call?id=7fc0c5b166556b20a1a76dd68c283240f27b594ffa889973caa8bc4b3839ddd4", "speakerId": "1987549102023084628", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "we have like seven or eight groups in BRC", "date": "2025-06-19", "callId": "2025-06-19_88c185821c1c", "gongUrl": "https://app.gong.io/call?id=88c185821c1cb55a23a5946c6f926e2be7cec155bf6ea0bc2e68b80a163f2cee", "speakerId": "3609994825051798874", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "we have, I don't even know six or so depart subgroups in our in BRC", "date": "2025-05-12", "callId": "2025-05-12_5d20900da889", "gongUrl": "https://app.gong.io/call?id=5d20900da889bcf638051b940c63606e012a4848dc0155134b468660bbef0754", "speakerId": "5807634562213611276", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "It's about my colleague from BRC, Nicole Balke.", "date": "2025-04-25", "callId": "2025-04-25_240583f0751a", "gongUrl": "https://app.gong.io/call?id=240583f0751a76fa2f6f91fe43a480004d666bdfbfce68d0e66ce5dff7455460", "speakerId": "1166084965768706461", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "Like, BRC has a lot of modalities coming in", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "2765675683771798832", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_discovery_sciences_bad5b9d3", "company": "novartis", "gong_entity": "Discovery Sciences", "gong_parent": "NIBR", "entity_type": "department", "team_size": "650", "confidence": "high", "mention_count": 6, "snippet": "I'm discovery sciences", "snippet_date": "2025-05-07", "person_name": "Khadijeh Alnajjar; Khadijeh Alnajjar", "person_email": "khadijeh.alnajjar@novartis.com; khadijeh.alnajjar@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0aaf4e097ebf6bfce9521a8788210dd832785aa1c579586709264e8114ee52cc", "call_id": "2025-05-07_0aaf4e097ebf", "call_count": 6, "all_snippets": [{"quote": "I'm discovery sciences", "date": "2025-05-07", "callId": "2025-05-07_0aaf4e097ebf", "gongUrl": "https://app.gong.io/call?id=0aaf4e097ebf6bfce9521a8788210dd832785aa1c579586709264e8114ee52cc", "speakerId": "5754257167915495091", "customerName": "Khadijeh Alnajjar; Khadijeh Alnajjar", "internalName": "Mackay O'Connor", "customerEmail": "khadijeh.alnajjar@novartis.com; khadijeh.alnajjar@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}, {"quote": "And then there's like discovery sciences and your DAX", "date": "2025-01-13", "callId": "2025-01-13_d36981559ab1", "gongUrl": "https://app.gong.io/call?id=d36981559ab16fa615cc63c28f36976d16eb2cc6b4793cd506b1c5d2c5e88c1e", "speakerId": "109613814220320311", "customerName": "Magali Saint-Geniez; Magali Saint-Geniez", "internalName": "Ross Proudfoot", "customerEmail": "magali.saint-geniez@novartis.com; magali.saint-geniez@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "So it's discovery science, yes.", "date": "2024-07-16", "callId": "2024-07-16_b1802f42603b", "gongUrl": "https://app.gong.io/call?id=b1802f42603bd622e51163b870bb362be7356157086948b9e5db0ad87e98dd82", "speakerId": "9036496746094861374", "customerName": "M\u00e9lanie Pellisson; M\u00e9lanie Pellisson", "internalName": "Jaden Dankevy", "customerEmail": "melanie.pellisson@novartis.com; melanie.pellisson@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "There was like a discovery science five seat from Alex from a while back", "date": "2024-06-21", "callId": "2024-06-21_3f5653421815", "gongUrl": "https://app.gong.io/call?id=3f56534218159fadf03a5e4dc86d19c5ac538eba2a7a2471e92d72add0e4ec64", "speakerId": "8730202880904642374", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "Discovery sciences though.", "date": "2024-06-07", "callId": "2024-06-07_3dc28ee91ae9", "gongUrl": "https://app.gong.io/call?id=3dc28ee91ae9430905a3b510d3e9528d91cd7d02c2c187fb3585f7e2e5ffd183", "speakerId": "6717905254518940385", "customerName": "Linda Chin; Sandra Calles", "internalName": "Ross Proudfoot; Tim Fung; Walid Habboub", "customerEmail": "linda.chin@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": []}, {"quote": "we're in a very big part of the organization called discovery sciences. It's about 650 people or something like that.", "date": "2023-12-05", "callId": "2023-12-05_59d91af76958", "gongUrl": "https://app.gong.io/call?id=59d91af76958d0ab95d7b81c80260cdc2293587cf0d4e10e20a2b31887470dbd", "speakerId": "4580508943786755568", "customerName": "Alexandre Bouzekri; Alexandre Bouzekri; Wendy Fantl; Wendy Fantl", "internalName": "Ross Proudfoot", "customerEmail": "alexandre.bouzekri@novartis.com; alexandre.bouzekri@novartis.com; wendy-1.fantl@novartis.com; wendy-1.fantl@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": [{"value": "650", "snippetIndex": 5, "source": {"callDate": "2023-12-05", "customerName": "Alexandre Bouzekri; Alexandre Bouzekri; Wendy Fantl; Wendy Fantl"}}]}]}, {"id": "novartis_imm_f11fbb2e", "company": "novartis", "gong_entity": "IMM", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 5, "snippet": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": {"manual_node_id": "immunology-research", "manual_node_name": "Immunology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Immunology", "confidence": "high", "reasoning": "IMM is a clear acronym for Immunology, matching the Immunology therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 5, "all_snippets": [{"quote": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "7027995544158346041", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "I will still be with one leg in IMM", "date": "2025-11-11", "callId": "2025-11-11_2414cb1b1435", "gongUrl": "https://app.gong.io/call?id=2414cb1b14350c13bcc8c1db5ba43b37822b50dd48f16100ff0cba8182771b36", "speakerId": "6048279280409577254", "customerName": "Petra Simic", "internalName": "Tim Fung", "customerEmail": "petra.simic@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": []}, {"quote": "I think originally, it was like IMM yourselves, and Dari", "date": "2025-11-11", "callId": "2025-11-11_f7c2ee51d20a", "gongUrl": "https://app.gong.io/call?id=f7c2ee51d20a106cf6751a506ff5556d0c12467a8559015818ae581fcab7c787", "speakerId": "7239136083605626808", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "how everything was going with the launch at IMM", "date": "2025-09-09", "callId": "2025-09-09_36a05d87bc8c", "gongUrl": "https://app.gong.io/call?id=36a05d87bc8c298c19147dbaf4cb7d3adf31aca52940ca4e2488d6f464bfebcf", "speakerId": "8542056939748835213", "customerName": "Petra Simic", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "petra.simic@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I'm part of the immunology disease area department", "date": "2025-02-14", "callId": "2025-02-14_8d21cc1916f8", "gongUrl": "https://app.gong.io/call?id=8d21cc1916f857d11532992d29b452609a30d3a6be656afbf85963925eb31c9d", "speakerId": "6596611703832285025", "customerName": "Giulia Montanelli", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "giulia.montanelli@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_pks_7b7df9fa", "company": "novartis", "gong_entity": "PKS", "gong_parent": "Translational Medicine", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "You did the demo with TM or PKS.", "snippet_date": "2025-09-26", "person_name": "Stefan Melly", "person_email": "stefan.melly@novartis.com; adam.tomaszewski@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmacokinetics-pharmacodynamics", "manual_node_name": "Pharmacokinetics & Pharmacodynamics", "manual_node_path": "Novartis Research & Development > Development > Clinical Pharmacology & Safety Sciences > Pharmacokinetics & Pharmacodynamics", "confidence": "medium", "reasoning": "PKS likely stands for Pharmacokinetics, which closely matches the Pharmacokinetics & Pharmacodynamics team"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cbfda20d68ec271c79e983fc73fa5ff628ad2fa284e674a2b05ec97ef8fcf38d", "call_id": "2025-09-26_cbfda20d68ec", "call_count": 2, "all_snippets": [{"quote": "You did the demo with TM or PKS.", "date": "2025-09-26", "callId": "2025-09-26_cbfda20d68ec", "gongUrl": "https://app.gong.io/call?id=cbfda20d68ec271c79e983fc73fa5ff628ad2fa284e674a2b05ec97ef8fcf38d", "speakerId": "376604606706690514", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I'm checking with the PKS PCS and cis guys. So those are all from translational medicine currently", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "2567351405035696877", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_analytical_development_02561f6e", "company": "novartis", "gong_entity": "Analytical Development", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "within analytical development as well", "snippet_date": "2024-04-22", "person_name": "Rok Kosir", "person_email": "rok.kosir@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-sciences-sm", "manual_node_name": "Analytical Sciences", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Analytical Sciences", "confidence": "medium", "reasoning": "Analytical Development closely matches Analytical Sciences - both relate to analytical work in pharmaceutical development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "call_id": "2024-04-22_c0f762e58a39", "call_count": 3, "all_snippets": [{"quote": "within analytical development as well", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "910876744940341148", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "Although that being said, I am a part of analytical development", "date": "2024-03-27", "callId": "2024-03-27_855f773b00e5", "gongUrl": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "speakerId": "171743836081310569", "customerName": "Prateek Tripathi", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "prateek.tripathi@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "We are working in analytical development.", "date": "2024-02-02", "callId": "2024-02-02_c1c1acf6a50e", "gongUrl": "https://app.gong.io/call?id=c1c1acf6a50e4d1ecb03563b098667b96d9f8173bcd785c48a9e2e4f3dd5634d", "speakerId": "4261159460555452472", "customerName": "Fabienne Schuetz", "internalName": "Ross Proudfoot", "customerEmail": "fabienne.schuetz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_dari_e87ce6dd", "company": "novartis", "gong_entity": "Dari", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 2, "all_snippets": [{"quote": "Dax, oncology, BRC, IMM, and Dari, all have full organizational like departmental licensing with us", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "7027995544158346041", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}, {"quote": "I think originally, it was like IMM yourselves, and Dari", "date": "2025-11-11", "callId": "2025-11-11_f7c2ee51d20a", "gongUrl": "https://app.gong.io/call?id=f7c2ee51d20a106cf6751a506ff5556d0c12467a8559015818ae581fcab7c787", "speakerId": "7239136083605626808", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_dare_17083538", "company": "novartis", "gong_entity": "DARE", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "stefa melli, actually from the dare department", "snippet_date": "2025-10-07", "person_name": "Francika Cerkini; Francika Cerkini; Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "person_email": "francika.cerkini@novartis.com; francika.cerkini@novartis.com; giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; songhita.das_dutt@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=a6f86cbf1feaf33da1cd5f989aff6139470e5f25a4903583ebe774bc84bde900", "call_id": "2025-10-07_a6f86cbf1fea", "call_count": 2, "all_snippets": [{"quote": "stefa melli, actually from the dare department", "date": "2025-10-07", "callId": "2025-10-07_a6f86cbf1fea", "gongUrl": "https://app.gong.io/call?id=a6f86cbf1feaf33da1cd5f989aff6139470e5f25a4903583ebe774bc84bde900", "speakerId": "2567550711970751141", "customerName": "Francika Cerkini; Francika Cerkini; Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "francika.cerkini@novartis.com; francika.cerkini@novartis.com; giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "I think Stefan mentioned there's only about 150 or so scientists in there", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "8312379094350391382", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_dsc_3f31c5ef", "company": "novartis", "gong_entity": "DSC", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I could really build on what Stefan had already done for DSC", "snippet_date": "2025-09-09", "person_name": "Petra Simic", "person_email": "petra.simic@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "data-sciences", "manual_node_name": "Data Sciences", "manual_node_path": "Novartis Research & Development > Data & Digital Technology (R&D) > Data Sciences", "confidence": "medium", "reasoning": "DSC likely stands for Data Sciences Center or similar, matching the Data Sciences department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=36a05d87bc8c298c19147dbaf4cb7d3adf31aca52940ca4e2488d6f464bfebcf", "call_id": "2025-09-09_36a05d87bc8c", "call_count": 2, "all_snippets": [{"quote": "I could really build on what Stefan had already done for DSC", "date": "2025-09-09", "callId": "2025-09-09_36a05d87bc8c", "gongUrl": "https://app.gong.io/call?id=36a05d87bc8c298c19147dbaf4cb7d3adf31aca52940ca4e2488d6f464bfebcf", "speakerId": "8262428371254335958", "customerName": "Petra Simic", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "petra.simic@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "we got to see quite a few people from oncology and from DSC", "date": "2025-07-03", "callId": "2025-07-03_ef14d537dd56", "gongUrl": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "speakerId": "982092049665086921", "customerName": "Jennifer Brogdon", "internalName": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "customerEmail": "jennifer.brogdon@novartis.com", "internalEmail": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_research_informatics_8f85cbf2", "company": "novartis", "gong_entity": "Research Informatics", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "So I'm part of the research informatics or data and digital, I think it's called now.", "snippet_date": "2025-08-07", "person_name": "Elizaveta Solovyeva", "person_email": "elizaveta.solovyeva@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "data-digital-technology", "manual_node_name": "Data & Digital Technology (R&D)", "manual_node_path": "Novartis Research & Development > Data & Digital Technology (R&D)", "confidence": "medium", "reasoning": "Research Informatics aligns with Data & Digital Technology division, as mentioned in the snippet that it's 'called data and digital now'"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c3730c2be6772f6d5a8817d603261d178c7c624c8b96340647f10629e291b076", "call_id": "2025-08-07_c3730c2be677", "call_count": 2, "all_snippets": [{"quote": "So I'm part of the research informatics or data and digital, I think it's called now.", "date": "2025-08-07", "callId": "2025-08-07_c3730c2be677", "gongUrl": "https://app.gong.io/call?id=c3730c2be6772f6d5a8817d603261d178c7c624c8b96340647f10629e291b076", "speakerId": "4131910138534504482", "customerName": "Elizaveta Solovyeva", "internalName": "Mackay O'Connor", "customerEmail": "elizaveta.solovyeva@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}, {"quote": "for example, we research informatics, we have also planned to reduce by 10 percent", "date": "2024-04-05", "callId": "2024-04-05_d4cec47e17d6", "gongUrl": "https://app.gong.io/call?id=d4cec47e17d64f874bacbea14e1dde4506fe7fc3b7bdd3ae90ce942d6ebdb943", "speakerId": "5554920252961853778", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_scientific_operations_95f27f88", "company": "novartis", "gong_entity": "Scientific Operations", "gong_parent": "NIBR", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm going to sciops scientific operations", "snippet_date": "2025-11-11", "person_name": "Petra Simic", "person_email": "petra.simic@novartis.com", "internal_name": "Tim Fung", "internal_email": "tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=2414cb1b14350c13bcc8c1db5ba43b37822b50dd48f16100ff0cba8182771b36", "call_id": "2025-11-11_2414cb1b1435", "call_count": 1, "all_snippets": [{"quote": "I'm going to sciops scientific operations", "date": "2025-11-11", "callId": "2025-11-11_2414cb1b1435", "gongUrl": "https://app.gong.io/call?id=2414cb1b14350c13bcc8c1db5ba43b37822b50dd48f16100ff0cba8182771b36", "speakerId": "6048279280409577254", "customerName": "Petra Simic", "internalName": "Tim Fung", "customerEmail": "petra.simic@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_dax_43a05954", "company": "novartis", "gong_entity": "Dax", "gong_parent": "Novartis", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "oncology is now brought on the same licensing that you guys have as well as Dax", "snippet_date": "2025-11-11", "person_name": "Nicole Balke", "person_email": "nicole.balke@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=f7c2ee51d20a106cf6751a506ff5556d0c12467a8559015818ae581fcab7c787", "call_id": "2025-11-11_f7c2ee51d20a", "call_count": 3, "all_snippets": [{"quote": "oncology is now brought on the same licensing that you guys have as well as Dax", "date": "2025-11-11", "callId": "2025-11-11_f7c2ee51d20a", "gongUrl": "https://app.gong.io/call?id=f7c2ee51d20a106cf6751a506ff5556d0c12467a8559015818ae581fcab7c787", "speakerId": "7239136083605626808", "customerName": "Nicole Balke", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nicole.balke@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "And so inside this deck, what you're going to find is just an overview of the license that Dax has.", "date": "2025-09-23", "callId": "2025-09-23_7132d1511a3d", "gongUrl": "https://app.gong.io/call?id=7132d1511a3dfe18975496fd0e6882184733f67bc2525a7e973b560e01231ee6", "speakerId": "3509689377289371235", "customerName": "Bianka Grosshans", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "bianka.grosshans@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "And then there's like discovery sciences and your DAX", "date": "2025-01-13", "callId": "2025-01-13_d36981559ab1", "gongUrl": "https://app.gong.io/call?id=d36981559ab16fa615cc63c28f36976d16eb2cc6b4793cd506b1c5d2c5e88c1e", "speakerId": "109613814220320311", "customerName": "Magali Saint-Geniez; Magali Saint-Geniez", "internalName": "Ross Proudfoot", "customerEmail": "magali.saint-geniez@novartis.com; magali.saint-geniez@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_slovenia_7c639bca", "company": "novartis", "gong_entity": "Slovenia", "gong_parent": "Novartis", "entity_type": "site", "team_size": null, "confidence": "medium", "mention_count": 3, "snippet": "I think it's Slovenia has a license", "snippet_date": "2025-08-27", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "call_id": "2025-08-27_ae4bb8bcbac3", "call_count": 3, "all_snippets": [{"quote": "I think it's Slovenia has a license", "date": "2025-08-27", "callId": "2025-08-27_ae4bb8bcbac3", "gongUrl": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "speakerId": "2604523071425011415", "customerName": "Robert Szabo", "internalName": "Ross Proudfoot", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "So we'll be upgrading like this new one out of Slovenia, I think it is.", "date": "2025-02-07", "callId": "2025-02-07_f780f2fabe76", "gongUrl": "https://app.gong.io/call?id=f780f2fabe76e4160207b613012ddce01cbb414b99143d7a2643e28aa733d032", "speakerId": "7871013341411051570", "customerName": "", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "So there are basically two teams, one in vegas in Slovenia and one in basil in Switzerland.", "date": "2024-02-20", "callId": "2024-02-20_56aed2d86447", "gongUrl": "https://app.gong.io/call?id=56aed2d864477a227556448ee58e819d5ac362ae15fd23445426b1f60e093b93", "speakerId": "4231809808949283905", "customerName": "Davor Obradovic", "internalName": "Ross Proudfoot", "customerEmail": "davor.obradovic@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_novartis_mexico_0a787ff8", "company": "novartis", "gong_entity": "Novartis Mexico", "gong_parent": "Novartis", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "Well here in artist Mexico, I'm working as a field medical educator", "snippet_date": "2025-01-31", "person_name": "Dennis Cerrato", "person_email": "dennis.cerrato@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=a25ce7e591bfa6dd9ddf9bcb1a144162c85052158133a19c1ff725046d46b306", "call_id": "2025-01-31_a25ce7e591bf", "call_count": 3, "all_snippets": [{"quote": "Well here in artist Mexico, I'm working as a field medical educator", "date": "2025-01-31", "callId": "2025-01-31_a25ce7e591bf", "gongUrl": "https://app.gong.io/call?id=a25ce7e591bfa6dd9ddf9bcb1a144162c85052158133a19c1ff725046d46b306", "speakerId": "829699745715724873", "customerName": "Dennis Cerrato", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "dennis.cerrato@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "here in Novartis Mexico, I'm a field medical educator", "date": "2025-01-29", "callId": "2025-01-29_63e8611ee363", "gongUrl": "https://app.gong.io/call?id=63e8611ee363334b7f259adbcfd64b8e662b0e41438c3f1b48a85ebf74f7fb40", "speakerId": "7287705195715936510", "customerName": "Dennis Cerrato", "internalName": "Jaden Dankevy", "customerEmail": "dennis.cerrato@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "But really, yeah, full groups that you can kind of wrap around like if you've got sort of like say even for Novartis Mexico, you've got, you know, 10 marketers and all that", "date": "2025-01-21", "callId": "2025-01-21_3ea6171fde87", "gongUrl": "https://app.gong.io/call?id=3ea6171fde87d6d8d30cafa5803d8de1bda697c4c00d8670add2d33337f8b7cb", "speakerId": "4627937995255245483", "customerName": "Elsie Gonzalez; Elsie Gonzalez", "internalName": "Ross Proudfoot", "customerEmail": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cto_b90d0cb4", "company": "novartis", "gong_entity": "CTO", "gong_parent": "Novartis", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 2, "snippet": "I think originally from CTO before sort of the evaluating licenses", "snippet_date": "2025-01-23", "person_name": "Andrea Lopez; Andrea Lopez", "person_email": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=1589b3e2489ee2516ed10da00f246bb45692d87cf6d04b749fb4ff5b63a0a2b3", "call_id": "2025-01-23_1589b3e2489e", "call_count": 2, "all_snippets": [{"quote": "I think originally from CTO before sort of the evaluating licenses", "date": "2025-01-23", "callId": "2025-01-23_1589b3e2489e", "gongUrl": "https://app.gong.io/call?id=1589b3e2489ee2516ed10da00f246bb45692d87cf6d04b749fb4ff5b63a0a2b3", "speakerId": "4175121140223552022", "customerName": "Andrea Lopez; Andrea Lopez", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "if you were to purchase 204 and that could be inclusive of other groups like TRD or CTO", "date": "2024-09-06", "callId": "2024-09-06_169896fe10d3", "gongUrl": "https://app.gong.io/call?id=169896fe10d3c8d7ef75c09e16265eb99e34ccc5d53a6ea03ba7c235f1c2ea02", "speakerId": "4790105840873293174", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_san_diego_3f8f1861", "company": "novartis", "gong_entity": "San Diego", "gong_parent": "Novartis", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I'm in San Diego site.", "snippet_date": "2024-12-09", "person_name": "Yang Yang; Yang Yang", "person_email": "yang-19.yang@novartis.com; yang-19.yang@novartis.com", "internal_name": "Jaden Dankevy; Matthew Gralewski", "internal_email": "jaden.dankevy@biorender.com; matt.gralewski@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=b3f230328cb17bda29606152ccba280b43f93115d56086062fb41cefdd58626c", "call_id": "2024-12-09_b3f230328cb1", "call_count": 2, "all_snippets": [{"quote": "I'm in San Diego site.", "date": "2024-12-09", "callId": "2024-12-09_b3f230328cb1", "gongUrl": "https://app.gong.io/call?id=b3f230328cb17bda29606152ccba280b43f93115d56086062fb41cefdd58626c", "speakerId": "4703226759175471640", "customerName": "Yang Yang; Yang Yang", "internalName": "Jaden Dankevy; Matthew Gralewski", "customerEmail": "yang-19.yang@novartis.com; yang-19.yang@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; matt.gralewski@biorender.com", "sizeMentions": []}, {"quote": "San Diego?", "date": "2024-03-27", "callId": "2024-03-27_855f773b00e5", "gongUrl": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "speakerId": "171743836081310569", "customerName": "Prateek Tripathi", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "prateek.tripathi@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_sandoz_ace44628", "company": "novartis", "gong_entity": "Sandoz", "gong_parent": "Novartis", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "She works for sandoz in another country", "snippet_date": "2025-11-19", "person_name": "Adam Tomaszewski; Chunping Chunping; Hannah Morgan; Phone Caller #1; Rok Kosir; Samu Melkko; Soumya Badrinath; Stefan Melly", "person_email": "adam.tomaszewski@novartis.com; chunping.qiao@novartis.com; hannah.morgan@novartis.com; rok.kosir@novartis.com; samu.melkko@novartis.com; soumya.badrinath@novartis.com; stefan.melly@novartis.com", "internal_name": "Lily Liu", "internal_email": "lily.liu@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=90c2f7253e4e76d7e60f7c2f008bd002648bab16eaabee59b7746b09a2743135", "call_id": "2025-11-19_90c2f7253e4e", "call_count": 1, "all_snippets": [{"quote": "She works for sandoz in another country", "date": "2025-11-19", "callId": "2025-11-19_90c2f7253e4e", "gongUrl": "https://app.gong.io/call?id=90c2f7253e4e76d7e60f7c2f008bd002648bab16eaabee59b7746b09a2743135", "speakerId": "5943995831723312501", "customerName": "Adam Tomaszewski; Chunping Chunping; Hannah Morgan; Phone Caller #1; Rok Kosir; Samu Melkko; Soumya Badrinath; Stefan Melly", "internalName": "Lily Liu", "customerEmail": "adam.tomaszewski@novartis.com; chunping.qiao@novartis.com; hannah.morgan@novartis.com; rok.kosir@novartis.com; samu.melkko@novartis.com; soumya.badrinath@novartis.com; stefan.melly@novartis.com", "internalEmail": "lily.liu@biorender.com", "sizeMentions": []}]}, {"id": "novartis_medical_information_16f9dbd1", "company": "novartis", "gong_entity": "Medical Information", "gong_parent": "Novartis", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm working in medical information", "snippet_date": "2025-12-15", "person_name": "Oliver Pohl", "person_email": "oliver.pohl@novartis.com", "internal_name": "Sofiya Medvezhonkova", "internal_email": "sofiya.m@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=af4b5d9111d778c95d0f4952a90fdfcfb6da57621b0ca4f70be43cc412c3d8da", "call_id": "2025-12-15_af4b5d9111d7", "call_count": 1, "all_snippets": [{"quote": "I'm working in medical information", "date": "2025-12-15", "callId": "2025-12-15_af4b5d9111d7", "gongUrl": "https://app.gong.io/call?id=af4b5d9111d778c95d0f4952a90fdfcfb6da57621b0ca4f70be43cc412c3d8da", "speakerId": "6058437699674532906", "customerName": "Oliver Pohl", "internalName": "Sofiya Medvezhonkova", "customerEmail": "oliver.pohl@novartis.com", "internalEmail": "sofiya.m@biorender.com", "sizeMentions": []}]}, {"id": "novartis_ddit_59da0eff", "company": "novartis", "gong_entity": "DDIT", "gong_parent": "Novartis", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "he's trying to set also some meeting up with the people from ddit", "snippet_date": "2025-10-10", "person_name": "Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "person_email": "giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "data-digital-technology", "manual_node_name": "Data & Digital Technology (R&D)", "manual_node_path": "Novartis Research & Development > Data & Digital Technology (R&D)", "confidence": "medium", "reasoning": "DDIT likely stands for Data & Digital Technology, matching the division name with reasonable acronym alignment"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a3c2d5b3a13c3cb31735eda09cbfdacf8c2e414dcbf190cd69ad1525ccade394", "call_id": "2025-10-10_a3c2d5b3a13c", "call_count": 1, "all_snippets": [{"quote": "he's trying to set also some meeting up with the people from ddit", "date": "2025-10-10", "callId": "2025-10-10_a3c2d5b3a13c", "gongUrl": "https://app.gong.io/call?id=a3c2d5b3a13c3cb31735eda09cbfdacf8c2e414dcbf190cd69ad1525ccade394", "speakerId": "2209671332130699400", "customerName": "Giuseppe Manco; Giuseppe Manco; Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "giuseppe.manco@novartis.com; giuseppe.manco@novartis.com; nathalie.teissier@novartis.com; nathalie.teissier@novartis.com; francika.cerkini@novartis.com; songhita.das_dutt@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_mechanistic_immunology_b264ac6b", "company": "novartis", "gong_entity": "Mechanistic Immunology", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 5, "snippet": "We worked with her in biologic mechanistic immunology with the smaller group", "snippet_date": "2024-05-10", "person_name": "Linda Chin", "person_email": "linda.chin@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "immunology-research", "manual_node_name": "Immunology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Immunology", "confidence": "medium", "reasoning": "Mechanistic Immunology is a specialized team within the broader Immunology therapeutic area, semantic match with parent alignment"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=859d7d55b37dc640b48f44ef0a7937490a477dd08b26e0ae81feb2c875fa9cda", "call_id": "2024-05-10_859d7d55b37d", "call_count": 5, "all_snippets": [{"quote": "We worked with her in biologic mechanistic immunology with the smaller group", "date": "2024-05-10", "callId": "2024-05-10_859d7d55b37d", "gongUrl": "https://app.gong.io/call?id=859d7d55b37dc640b48f44ef0a7937490a477dd08b26e0ae81feb2c875fa9cda", "speakerId": "7419921050103242439", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}, {"quote": "It might be the mechanisic immunology group was the smaller group that I spoke with", "date": "2023-05-15", "callId": "2023-05-15_834463ba859f", "gongUrl": "https://app.gong.io/call?id=834463ba859fdc25932eb4580c1c5cca1d1907b5eccc809914809949a9749922", "speakerId": "2582612001647862875", "customerName": "Nadia Hassounah", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "nadia.hassounah@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "So like typically, what we've done, we just did it with mechanistic immunology group as we quoted them for essentially a certain portion of seats with some deployable free seats so that some new users could try it out.", "date": "2023-05-11", "callId": "2023-05-11_e2222ded4d9a", "gongUrl": "https://app.gong.io/call?id=e2222ded4d9ad292eecf0f2a9b06e8dd0c0183e6ce2d3a86a6ea1e83e2a43167", "speakerId": "2801323370655851122", "customerName": "Agnieszka Kabat", "internalName": "Ross Proudfoot", "customerEmail": "aga.kabat@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}, {"quote": "We are a little unit called the mechanistic immunology and we are spread between here base and cambridge", "date": "2023-03-24", "callId": "2023-03-24_58030a251dad", "gongUrl": "https://app.gong.io/call?id=58030a251dad973bd8ec4d9536d4b3ec0635d48e7dc59049f1ada7ed9d7c72bd", "speakerId": "5888632718747090059", "customerName": "Francesca Rucci; Vanessa Cornacchione", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "francesca.rucci@novartis.com; vanessa.cornacchione@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "We've done a mechanical mechanic immunology has purchased like, so they put in for a right to deploy", "date": "2023-06-01", "callId": "2023-06-01_31203cfb25be", "gongUrl": "https://app.gong.io/call?id=31203cfb25bee498967f6c5b819459d8686a8c4828b2ec7a8cae9dbe0d137326", "speakerId": "3694172438092133148", "customerName": "Khadijeh Alnajjar; Khadijeh Alnajjar", "internalName": "Ross Proudfoot", "customerEmail": "khadijeh.alnajjar@novartis.com; khadijeh.alnajjar@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biologics_research_center_0d65dac5", "company": "novartis", "gong_entity": "Biologics Research Center", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "So the B, let's say biologic center and there's a CGT sub team, so, but it's still under the, but, yeah, it's still under the BR", "snippet_date": "2025-02-19", "person_name": "Rongqiang Yang", "person_email": "rongqiang.yang@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development", "manual_node_name": "Biologics Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development", "confidence": "medium", "reasoning": "Fuzzy match - 'Biologics Research Center' aligns with 'Biologics Development' department, both focused on biologics work"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c8792a337b0a52bb5b1aaac29b88ffc414647107b7b5b689a4920ab0d391a116", "call_id": "2025-02-19_c8792a337b0a", "call_count": 2, "all_snippets": [{"quote": "So the B, let's say biologic center and there's a CGT sub team, so, but it's still under the, but, yeah, it's still under the BR", "date": "2025-02-19", "callId": "2025-02-19_c8792a337b0a", "gongUrl": "https://app.gong.io/call?id=c8792a337b0a52bb5b1aaac29b88ffc414647107b7b5b689a4920ab0d391a116", "speakerId": "7926109428293961304", "customerName": "Rongqiang Yang", "internalName": "Jaden Dankevy", "customerEmail": "rongqiang.yang@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}, {"quote": "We're part of the Biologics Research Center, which used to be the Novartis Biologic Center, just the Biologics Department.", "date": "2024-11-21", "callId": "2024-11-21_3c1201312957", "gongUrl": "https://app.gong.io/call?id=3c120131295784689204cc9187c1eab00fce6cf8daed7a2d12f422e8f9fb2c0f", "speakerId": "2676158906284496827", "customerName": "Joni Lam", "internalName": "Jaden Dankevy", "customerEmail": "joni.lam@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cgt_b61919a6", "company": "novartis", "gong_entity": "CGT", "gong_parent": "Biologics Research Center", "entity_type": "sub_team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Yeah, we are under the CGT. So the B, let's say biologic center and there's a CGT sub team", "snippet_date": "2025-02-19", "person_name": "Rongqiang Yang", "person_email": "rongqiang.yang@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "cell-gene-therapy-development", "manual_node_name": "Cell & Gene Therapy Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Cell & Gene Therapy Development", "confidence": "high", "reasoning": "Exact acronym match - CGT clearly stands for Cell & Gene Therapy, confirmed by context mentioning it's under biologics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c8792a337b0a52bb5b1aaac29b88ffc414647107b7b5b689a4920ab0d391a116", "call_id": "2025-02-19_c8792a337b0a", "call_count": 1, "all_snippets": [{"quote": "Yeah, we are under the CGT. So the B, let's say biologic center and there's a CGT sub team", "date": "2025-02-19", "callId": "2025-02-19_c8792a337b0a", "gongUrl": "https://app.gong.io/call?id=c8792a337b0a52bb5b1aaac29b88ffc414647107b7b5b689a4920ab0d391a116", "speakerId": "7926109428293961304", "customerName": "Rongqiang Yang", "internalName": "Jaden Dankevy", "customerEmail": "rongqiang.yang@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_aging_and_regenerative_disease_b37d1ec7", "company": "novartis", "gong_entity": "Aging and Regenerative Disease", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "we're currently working with a team in RD, aging and regenerative disease at Novartis", "snippet_date": "2025-01-31", "person_name": "Dennis Cerrato", "person_email": "dennis.cerrato@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=a25ce7e591bfa6dd9ddf9bcb1a144162c85052158133a19c1ff725046d46b306", "call_id": "2025-01-31_a25ce7e591bf", "call_count": 3, "all_snippets": [{"quote": "we're currently working with a team in RD, aging and regenerative disease at Novartis", "date": "2025-01-31", "callId": "2025-01-31_a25ce7e591bf", "gongUrl": "https://app.gong.io/call?id=a25ce7e591bfa6dd9ddf9bcb1a144162c85052158133a19c1ff725046d46b306", "speakerId": "1366738381323594192", "customerName": "Dennis Cerrato", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "dennis.cerrato@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "So like aging and regenerative diseases have kept their license separate from the general BR license", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "5430927708339458581", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "The 10 seats for aging and regenerative medicine actually renew a bit earlier than the central license.", "date": "2024-09-13", "callId": "2024-09-13_9c9e823685d8", "gongUrl": "https://app.gong.io/call?id=9c9e823685d8032a957502deb02b1bfc6fe68bd83d1541948e06a20283b54785", "speakerId": "1268202802418330215", "customerName": "Linda Chin", "internalName": "Tim Fung", "customerEmail": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_procurement_organization_2aa0c549", "company": "novartis", "gong_entity": "Procurement Organization", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I come from procurement", "snippet_date": "2024-04-26", "person_name": "Linda Chin; Sandra Calles", "person_email": "linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com; adam.tomaszewski@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung; Walid Habboub", "internal_email": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e278e1289677fc505e6a1ef9d80a9f2ed25496c127e20e50785e0ef433e846b", "call_id": "2024-04-26_9e278e128967", "call_count": 2, "all_snippets": [{"quote": "I come from procurement", "date": "2024-04-26", "callId": "2024-04-26_9e278e128967", "gongUrl": "https://app.gong.io/call?id=9e278e1289677fc505e6a1ef9d80a9f2ed25496c127e20e50785e0ef433e846b", "speakerId": "2408185159837381386", "customerName": "Linda Chin; Sandra Calles", "internalName": "Ross Proudfoot; Tim Fung; Walid Habboub", "customerEmail": "linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": []}, {"quote": "So I'm part of the dit procurement organization.", "date": "2024-02-16", "callId": "2024-02-16_c164bf745a9d", "gongUrl": "https://app.gong.io/call?id=c164bf745a9d13f0ca0273f4f4f01414b99c837cb11c1a42b8cadb349d0871d6", "speakerId": "2811482639573951853", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Carlos-2 Lopez; Gary Edwards; Hernandez, Edson; Linda Chin; Sandra Calles", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; carlos-2.lopez_ext@novartis.com; gary.edwards@novartis.com; edson.hernandez@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_us_procurement_team_62e905cd", "company": "novartis", "gong_entity": "US Procurement Team", "gong_parent": "Procurement Organization", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of it, us procurement team", "snippet_date": "2024-04-26", "person_name": "Linda Chin; Sandra Calles", "person_email": "linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com; adam.tomaszewski@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung; Walid Habboub", "internal_email": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e278e1289677fc505e6a1ef9d80a9f2ed25496c127e20e50785e0ef433e846b", "call_id": "2024-04-26_9e278e128967", "call_count": 1, "all_snippets": [{"quote": "I'm part of it, us procurement team", "date": "2024-04-26", "callId": "2024-04-26_9e278e128967", "gongUrl": "https://app.gong.io/call?id=9e278e1289677fc505e6a1ef9d80a9f2ed25496c127e20e50785e0ef433e846b", "speakerId": "2408185159837381386", "customerName": "Linda Chin; Sandra Calles", "internalName": "Ross Proudfoot; Tim Fung; Walid Habboub", "customerEmail": "linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cell_and_gene_therapy_774fdb1f", "company": "novartis", "gong_entity": "Cell and Gene Therapy", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I lead cell and gene therapy group", "snippet_date": "2025-07-03", "person_name": "Jennifer Brogdon", "person_email": "jennifer.brogdon@novartis.com", "internal_name": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "internal_email": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "cell-gene-therapy-development", "manual_node_name": "Cell & Gene Therapy Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Cell & Gene Therapy Development", "confidence": "high", "reasoning": "Exact match - 'Cell and Gene Therapy' matches 'Cell & Gene Therapy Development' with only minor formatting difference"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "call_id": "2025-07-03_ef14d537dd56", "call_count": 2, "all_snippets": [{"quote": "I lead cell and gene therapy group", "date": "2025-07-03", "callId": "2025-07-03_ef14d537dd56", "gongUrl": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "speakerId": "1484652332788337034", "customerName": "Jennifer Brogdon", "internalName": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "customerEmail": "jennifer.brogdon@novartis.com", "internalEmail": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "I'm in Cell and Gene Therapy.", "date": "2024-11-21", "callId": "2024-11-21_3c1201312957", "gongUrl": "https://app.gong.io/call?id=3c120131295784689204cc9187c1eab00fce6cf8daed7a2d12f422e8f9fb2c0f", "speakerId": "2676158906284496827", "customerName": "Joni Lam", "internalName": "Jaden Dankevy", "customerEmail": "joni.lam@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cell_therapy_operations_40bfd854", "company": "novartis", "gong_entity": "Cell Therapy Operations", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I'm the director north for cell therapy operations or north of the U. S for cell therapy operations for the company", "snippet_date": "2025-05-30", "person_name": "Andrea Lopez; Andrea Lopez; Margarida Rodrigues", "person_email": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com; margarida.rodrigues@novartis.com", "internal_name": "Michael Stanfel; Ross Proudfoot; Samara Ona", "internal_email": "michael.stanfel@biorender.com; ross@biorender.com; samara@biorender.com", "llm_suggested_match": {"manual_node_id": "car-t-platform", "manual_node_name": "CAR-T Cell Therapy Platform", "manual_node_path": "Novartis Research & Development > Platform Technologies & Capabilities > CAR-T Cell Therapy Platform", "confidence": "medium", "reasoning": "Partial match - operations aspect of cell therapy could align with CAR-T platform, though not a perfect fit"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b33750619542fd96920dab82868877482077bdaeba36f933b577c8fb2d0f55f3", "call_id": "2025-05-30_b33750619542", "call_count": 2, "all_snippets": [{"quote": "I'm the director north for cell therapy operations or north of the U. S for cell therapy operations for the company", "date": "2025-05-30", "callId": "2025-05-30_b33750619542", "gongUrl": "https://app.gong.io/call?id=b33750619542fd96920dab82868877482077bdaeba36f933b577c8fb2d0f55f3", "speakerId": "1085365343058888345", "customerName": "Andrea Lopez; Andrea Lopez; Margarida Rodrigues", "internalName": "Michael Stanfel; Ross Proudfoot; Samara Ona", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com; margarida.rodrigues@novartis.com", "internalEmail": "michael.stanfel@biorender.com; ross@biorender.com; samara@biorender.com", "sizeMentions": []}, {"quote": "Cell Therapy, Operations Managers.", "date": "2025-01-10", "callId": "2025-01-10_e4f1c39631f6", "gongUrl": "https://app.gong.io/call?id=e4f1c39631f6aef0211c0fd45bedf808cac4484f27e8c9b13510b84bdd8e54bf", "speakerId": "6675217776239111794", "customerName": "Andrea Lopez; Andrea Lopez", "internalName": "Jaden Dankevy", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cvrm_730b2cee", "company": "novartis", "gong_entity": "CVRM", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "And, I think within cvrm, I do think we have, a load of users within that group as well", "snippet_date": "2025-02-20", "person_name": "Hayley Kim; Hayley Kim", "person_email": "hayley.kim@novartis.com; hayley.kim@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "cardiovascular-renal-metabolic", "manual_node_name": "Cardiovascular, Renal & Metabolic Diseases", "manual_node_path": "Novartis Research & Development > Biomedical Research > Cardiovascular, Renal & Metabolic Diseases", "confidence": "high", "reasoning": "Exact acronym match - CVRM clearly stands for Cardiovascular, Renal & Metabolic"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=8d3641b3d9a76b9da66c9091c7f17518f7030ea29ec521978f378e72feeb193d", "call_id": "2025-02-20_8d3641b3d9a7", "call_count": 2, "all_snippets": [{"quote": "And, I think within cvrm, I do think we have, a load of users within that group as well", "date": "2025-02-20", "callId": "2025-02-20_8d3641b3d9a7", "gongUrl": "https://app.gong.io/call?id=8d3641b3d9a76b9da66c9091c7f17518f7030ea29ec521978f378e72feeb193d", "speakerId": "8902340859018109944", "customerName": "Hayley Kim; Hayley Kim", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "hayley.kim@novartis.com; hayley.kim@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "So, I mean, right now, I'm in CVM which is the cardiovascular and metabolic disease group.", "date": "2025-01-10", "callId": "2025-01-10_9e7222a482fb", "gongUrl": "https://app.gong.io/call?id=9e7222a482fb050fd6ee6838be736f9284bf15a1a14b3229206f6f355fc1ace8", "speakerId": "766346542485550655", "customerName": "Ivan Barrera", "internalName": "Jaden Dankevy", "customerEmail": "ivan.barrera@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_chemical_biology_and_therapeutics_b139019d", "company": "novartis", "gong_entity": "Chemical Biology and Therapeutics", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We're chemical biology and therapeutics, CBT.", "snippet_date": "2023-06-01", "person_name": "Khadijeh Alnajjar; Khadijeh Alnajjar", "person_email": "khadijeh.alnajjar@novartis.com; khadijeh.alnajjar@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=31203cfb25bee498967f6c5b819459d8686a8c4828b2ec7a8cae9dbe0d137326", "call_id": "2023-06-01_31203cfb25be", "call_count": 1, "all_snippets": [{"quote": "We're chemical biology and therapeutics, CBT.", "date": "2023-06-01", "callId": "2023-06-01_31203cfb25be", "gongUrl": "https://app.gong.io/call?id=31203cfb25bee498967f6c5b819459d8686a8c4828b2ec7a8cae9dbe0d137326", "speakerId": "6688976700594068259", "customerName": "Khadijeh Alnajjar; Khadijeh Alnajjar", "internalName": "Ross Proudfoot", "customerEmail": "khadijeh.alnajjar@novartis.com; khadijeh.alnajjar@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_tdmp_88f9f923", "company": "novartis", "gong_entity": "TDMP", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I sit in tdmp which is target discovery and profiling", "snippet_date": "2025-12-04", "person_name": "Albert Misko", "person_email": "albert.misko@novartis.com", "internal_name": "Ross Proudfoot; Sofiya Medvezhonkova", "internal_email": "ross@biorender.com; sofiya.m@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "call_id": "2025-12-04_9b50b1639ecf", "call_count": 1, "all_snippets": [{"quote": "So I sit in tdmp which is target discovery and profiling", "date": "2025-12-04", "callId": "2025-12-04_9b50b1639ecf", "gongUrl": "https://app.gong.io/call?id=9b50b1639ecf5aaed5db8d27bfc49d4f79618c5553ad975ba0cbb14c51ecdaf5", "speakerId": "540529526687666601", "customerName": "Albert Misko", "internalName": "Ross Proudfoot; Sofiya Medvezhonkova", "customerEmail": "albert.misko@novartis.com", "internalEmail": "ross@biorender.com; sofiya.m@biorender.com", "sizeMentions": []}]}, {"id": "novartis_drc_b43d8823", "company": "novartis", "gong_entity": "DRC", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "So if we look at like DRC or some of the other groups that might have like 30 percent growth through the pilot period", "snippet_date": "2025-09-18", "person_name": "Stefan Melly", "person_email": "stefan.melly@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e103181fbb6334420894f40a9b0056365e997f6c790f775a3d2d2dc8205168b", "call_id": "2025-09-18_9e103181fbb6", "call_count": 1, "all_snippets": [{"quote": "So if we look at like DRC or some of the other groups that might have like 30 percent growth through the pilot period", "date": "2025-09-18", "callId": "2025-09-18_9e103181fbb6", "gongUrl": "https://app.gong.io/call?id=9e103181fbb6334420894f40a9b0056365e997f6c790f775a3d2d2dc8205168b", "speakerId": "8047766281425094527", "customerName": "Stefan Melly", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "stefan.melly@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_novartis_biomedical_research_44ccd7c5", "company": "novartis", "gong_entity": "Novartis Biomedical Research", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "novartis biomedical research got like the collective agreement", "snippet_date": "2025-08-27", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "high", "reasoning": "Exact match - entity refers to the Biomedical Research division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "call_id": "2025-08-27_ae4bb8bcbac3", "call_count": 1, "all_snippets": [{"quote": "novartis biomedical research got like the collective agreement", "date": "2025-08-27", "callId": "2025-08-27_ae4bb8bcbac3", "gongUrl": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "speakerId": "7015016855544201927", "customerName": "Robert Szabo", "internalName": "Ross Proudfoot", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_br_group_345876db", "company": "novartis", "gong_entity": "BR Group", "gong_parent": "Novartis Biomedical Research", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Are you a part of biomedical research then like the BR group?", "snippet_date": "2024-10-04", "person_name": "Shwetha Iyer", "person_email": "shwetha.iyer@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "medium", "reasoning": "BR likely stands for Biomedical Research based on context mentioning 'biomedical research'"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "call_id": "2024-10-04_d3321342d25a", "call_count": 1, "all_snippets": [{"quote": "Are you a part of biomedical research then like the BR group?", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "5430927708339458581", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biomedical_research_center_e05e8aa2", "company": "novartis", "gong_entity": "Biomedical Research Center", "gong_parent": "Novartis Biomedical Research", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we are actually the formulation team in biomedical research center.", "snippet_date": "2024-10-04", "person_name": "Shwetha Iyer", "person_email": "shwetha.iyer@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "medium", "reasoning": "Similar name to Biomedical Research division, likely referring to the same organizational unit"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "call_id": "2024-10-04_d3321342d25a", "call_count": 1, "all_snippets": [{"quote": "So we are actually the formulation team in biomedical research center.", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "2765675683771798832", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_formulation_team_25b434a0", "company": "novartis", "gong_entity": "Formulation Team", "gong_parent": "Biomedical Research Center", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we are actually the formulation team in biomedical research center. So it is biomedical research center is a bigger organization, which is all under VR, which is biomedical research and biomedical research center, or I think it's biotherapeutic research center, something like that. Like, BRC has a lot of modalities coming in, so like, you know, biologics, gene therapy space and everything. And my team is a very small team", "snippet_date": "2024-10-04", "person_name": "Shwetha Iyer", "person_email": "shwetha.iyer@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-development", "manual_node_name": "Pharmaceutical Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Pharmaceutical Development", "confidence": "medium", "reasoning": "Formulation work typically falls under pharmaceutical development activities"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "call_id": "2024-10-04_d3321342d25a", "call_count": 1, "all_snippets": [{"quote": "So we are actually the formulation team in biomedical research center. So it is biomedical research center is a bigger organization, which is all under VR, which is biomedical research and biomedical research center, or I think it's biotherapeutic research center, something like that. Like, BRC has a lot of modalities coming in, so like, you know, biologics, gene therapy space and everything. And my team is a very small team", "date": "2024-10-04", "callId": "2024-10-04_d3321342d25a", "gongUrl": "https://app.gong.io/call?id=d3321342d25a6a35e8ba18d106cb31dd11f5ec75aeed1b5eb4c9080fe232f6c0", "speakerId": "2765675683771798832", "customerName": "Shwetha Iyer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "shwetha.iyer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_formulation_development_f8b989cb", "company": "novartis", "gong_entity": "Formulation Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I work here only in Basel in like formulation development", "snippet_date": "2025-08-27", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-development", "manual_node_name": "Pharmaceutical Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Pharmaceutical Development", "confidence": "medium", "reasoning": "Formulation development is a core function of pharmaceutical development teams"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "call_id": "2025-08-27_ae4bb8bcbac3", "call_count": 1, "all_snippets": [{"quote": "So I work here only in Basel in like formulation development", "date": "2025-08-27", "callId": "2025-08-27_ae4bb8bcbac3", "gongUrl": "https://app.gong.io/call?id=ae4bb8bcbac3507ddca41394169709f1bad8374e8289c724aeabcfcbcd6f8907", "speakerId": "7015016855544201927", "customerName": "Robert Szabo", "internalName": "Ross Proudfoot", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_data_and_digital_65e379a2", "company": "novartis", "gong_entity": "Data and Digital", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm part of the research informatics or data and digital, I think it's called now.", "snippet_date": "2025-08-07", "person_name": "Elizaveta Solovyeva", "person_email": "elizaveta.solovyeva@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "data-digital-technology", "manual_node_name": "Data & Digital Technology (R&D)", "manual_node_path": "Novartis Research & Development > Data & Digital Technology (R&D)", "confidence": "high", "reasoning": "Very close match to Data & Digital Technology division name"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c3730c2be6772f6d5a8817d603261d178c7c624c8b96340647f10629e291b076", "call_id": "2025-08-07_c3730c2be677", "call_count": 1, "all_snippets": [{"quote": "So I'm part of the research informatics or data and digital, I think it's called now.", "date": "2025-08-07", "callId": "2025-08-07_c3730c2be677", "gongUrl": "https://app.gong.io/call?id=c3730c2be6772f6d5a8817d603261d178c7c624c8b96340647f10629e291b076", "speakerId": "4131910138534504482", "customerName": "Elizaveta Solovyeva", "internalName": "Mackay O'Connor", "customerEmail": "elizaveta.solovyeva@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_global_development_8d8d1a49", "company": "novartis", "gong_entity": "Global Development", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "there's biomedical research and then there's global development", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "global-drug-development", "manual_node_name": "Global Drug Development", "manual_node_path": "Novartis Research & Development > Development > Global Drug Development", "confidence": "medium", "reasoning": "Similar name and context suggests this refers to Global Drug Development department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "there's biomedical research and then there's global development", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_drug_development_86d2ae8a", "company": "novartis", "gong_entity": "Drug Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So drug development, we're exactly in the drug development", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "global-drug-development", "manual_node_name": "Global Drug Development", "manual_node_path": "Novartis Research & Development > Development > Global Drug Development", "confidence": "medium", "reasoning": "Drug development activities would fall under Global Drug Development department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "So drug development, we're exactly in the drug development", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_technical_drug_development_3676f776", "company": "novartis", "gong_entity": "Technical Drug Development", "gong_parent": "Drug Development", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "then further down to TRD, actually technical drug development", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences", "manual_node_name": "Pharmaceutical Sciences (Technical R&D)", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D)", "confidence": "medium", "reasoning": "Technical drug development aligns with Pharmaceutical Sciences (Technical R&D) division activities"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "then further down to TRD, actually technical drug development", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_new_chemical_entities_b39f47ba", "company": "novartis", "gong_entity": "New Chemical Entities", "gong_parent": "Technical Drug Development", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "going into new chemical entities, and then further down to TRD, actually technical drug development, and then new chemical entities", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "small-molecule-development", "manual_node_name": "Small Molecule Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development", "confidence": "medium", "reasoning": "New Chemical Entities typically refers to small molecule drug development activities, which aligns with Small Molecule Development department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "going into new chemical entities, and then further down to TRD, actually technical drug development, and then new chemical entities", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_early_phase_oral_a1223041", "company": "novartis", "gong_entity": "Early Phase Oral", "gong_parent": "New Chemical Entities", "entity_type": "sub_team", "team_size": "20", "confidence": "high", "mention_count": 1, "snippet": "So I'm like early phase oral and we are, I don't know like 20", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-development", "manual_node_name": "Pharmaceutical Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Pharmaceutical Development", "confidence": "medium", "reasoning": "Early phase oral formulation work would typically fall under Pharmaceutical Development team within small molecule development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "So I'm like early phase oral and we are, I don't know like 20", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_science_and_operations_db6ede0c", "company": "novartis", "gong_entity": "Science and Operations", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": "20", "confidence": "high", "mention_count": 1, "snippet": "So science and operations and we're probably the bigger group is around 20", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "So science and operations and we're probably the bigger group is around 20", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_analytics_7b6f1726", "company": "novartis", "gong_entity": "Analytics", "gong_parent": "Science and Operations", "entity_type": "team", "team_size": "20", "confidence": "high", "mention_count": 1, "snippet": "And for me, I've been also in analytics. So science and operations and we're probably the bigger group is around 20, but we're like a subgroup. So we're probably give or take seven, eight people", "snippet_date": "2025-08-05", "person_name": "Marina Statelova; Robert Szabo", "person_email": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-sciences-sm", "manual_node_name": "Analytical Sciences", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Analytical Sciences", "confidence": "high", "reasoning": "Analytics clearly maps to Analytical Sciences team, and context suggests small molecule focus"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "call_id": "2025-08-05_26ca3993d2f7", "call_count": 1, "all_snippets": [{"quote": "And for me, I've been also in analytics. So science and operations and we're probably the bigger group is around 20, but we're like a subgroup. So we're probably give or take seven, eight people", "date": "2025-08-05", "callId": "2025-08-05_26ca3993d2f7", "gongUrl": "https://app.gong.io/call?id=26ca3993d2f7538b0c96cdfe1a0b37d7651c7777a3a9672114e72b94497b24b1", "speakerId": "7686420687336281439", "customerName": "Marina Statelova; Robert Szabo", "internalName": "Mackay O'Connor", "customerEmail": "marina.statelova@novartis.com; robert-1.szabo@novartis.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": []}]}, {"id": "novartis_basel_vr_7e091414", "company": "novartis", "gong_entity": "Basel VR", "gong_parent": "Novartis R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So it's kind of VR level or Basel VR", "snippet_date": "2025-07-04", "person_name": "Zuni Bassi", "person_email": "zuni.bassi@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "basel-switzerland", "manual_node_name": "Basel, Switzerland (Global HQ & Primary R&D Hub)", "manual_node_path": "Novartis Research & Development > Global R&D Sites > Basel, Switzerland (Global HQ & Primary R&D Hub)", "confidence": "high", "reasoning": "Basel VR clearly refers to Basel site location, exact geographic match"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=8e4009585731cfafa3e9eafd1b9b09f5ee3d12a80df4ee555644aa6d7d7effe6", "call_id": "2025-07-04_8e4009585731", "call_count": 1, "all_snippets": [{"quote": "So it's kind of VR level or Basel VR", "date": "2025-07-04", "callId": "2025-07-04_8e4009585731", "gongUrl": "https://app.gong.io/call?id=8e4009585731cfafa3e9eafd1b9b09f5ee3d12a80df4ee555644aa6d7d7effe6", "speakerId": "3626252761295043604", "customerName": "Zuni Bassi", "internalName": "Ross Proudfoot", "customerEmail": "zuni.bassi@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_california_456202a7", "company": "novartis", "gong_entity": "California", "gong_parent": "Novartis R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "She's out in California", "snippet_date": "2025-07-03", "person_name": "Jennifer Brogdon", "person_email": "jennifer.brogdon@novartis.com", "internal_name": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "internal_email": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "emeryville-ca", "manual_node_name": "Emeryville, CA, USA", "manual_node_path": "Novartis Research & Development > Global R&D Sites > Emeryville, CA, USA", "confidence": "medium", "reasoning": "California reference most likely refers to Emeryville site, which is Novartis's main California R&D location"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "call_id": "2025-07-03_ef14d537dd56", "call_count": 1, "all_snippets": [{"quote": "She's out in California", "date": "2025-07-03", "callId": "2025-07-03_ef14d537dd56", "gongUrl": "https://app.gong.io/call?id=ef14d537dd56e43c3ac7814ef8754a1391577d31e0d2c6a5860412113dd949ee", "speakerId": "1484652332788337034", "customerName": "Jennifer Brogdon", "internalName": "Anne Granger; Mackay O'Connor; Ross Proudfoot", "customerEmail": "jennifer.brogdon@novartis.com", "internalEmail": "anne.granger@biorender.com; mackay.oconnor@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_auc_eef042c4", "company": "novartis", "gong_entity": "AUC", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I open the licenses for everyone in auc", "snippet_date": "2025-04-22", "person_name": "Nathalie Teissier; Nathalie Teissier", "person_email": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "call_id": "2025-04-22_eadcc63b7b0b", "call_count": 1, "all_snippets": [{"quote": "I open the licenses for everyone in auc", "date": "2025-04-22", "callId": "2025-04-22_eadcc63b7b0b", "gongUrl": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "speakerId": "8432339154031794193", "customerName": "Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_ioh_b7411904", "company": "novartis", "gong_entity": "IOH", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I have no idea what like CVM and ioh and the other groups are doing", "snippet_date": "2025-04-22", "person_name": "Nathalie Teissier; Nathalie Teissier", "person_email": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "call_id": "2025-04-22_eadcc63b7b0b", "call_count": 1, "all_snippets": [{"quote": "I have no idea what like CVM and ioh and the other groups are doing", "date": "2025-04-22", "callId": "2025-04-22_eadcc63b7b0b", "gongUrl": "https://app.gong.io/call?id=eadcc63b7b0bf4022a961fcfacce3e1a3be23cb9c435a84689d570178f499c14", "speakerId": "8432339154031794193", "customerName": "Nathalie Teissier; Nathalie Teissier", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_stefan's_team_71104879", "company": "novartis", "gong_entity": "Stefan's Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "she also didn't have the diary people from Stefan's team", "snippet_date": "2025-04-16", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "call_id": "2025-04-16_0ed32b9f3917", "call_count": 1, "all_snippets": [{"quote": "she also didn't have the diary people from Stefan's team", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "2567351405035696877", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cis_db4d542e", "company": "novartis", "gong_entity": "CIS", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm checking with the PKS PCS and cis guys. So those are all from translational medicine currently", "snippet_date": "2025-04-16", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "call_id": "2025-04-16_0ed32b9f3917", "call_count": 1, "all_snippets": [{"quote": "I'm checking with the PKS PCS and cis guys. So those are all from translational medicine currently", "date": "2025-04-16", "callId": "2025-04-16_0ed32b9f3917", "gongUrl": "https://app.gong.io/call?id=0ed32b9f3917ab20a34cd65d8d0318286c374126df243c1396c80ca24384a4fb", "speakerId": "2567351405035696877", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_immunology_dermatology_department_6c82bb54", "company": "novartis", "gong_entity": "Immunology Dermatology Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm in the immunology dermatology department.", "snippet_date": "2025-03-03", "person_name": "Brice Arnold", "person_email": "brice.arnold@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "immunology-research", "manual_node_name": "Immunology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Immunology", "confidence": "medium", "reasoning": "Partial match - entity mentions immunology which aligns with the Immunology therapeutic area, though dermatology is not explicitly mentioned in the manual org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=13b8fe3cb63c197fb64faba329351f624b279f61cbe5f76ce94dc5d290cc3404", "call_id": "2025-03-03_13b8fe3cb63c", "call_count": 1, "all_snippets": [{"quote": "I'm in the immunology dermatology department.", "date": "2025-03-03", "callId": "2025-03-03_13b8fe3cb63c", "gongUrl": "https://app.gong.io/call?id=13b8fe3cb63c197fb64faba329351f624b279f61cbe5f76ce94dc5d290cc3404", "speakerId": "8325959687875234852", "customerName": "Brice Arnold", "internalName": "Jaden Dankevy", "customerEmail": "brice.arnold@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_brand_team_376524c7", "company": "novartis", "gong_entity": "Brand Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "I think what we have to do is just to wait for the brand team to answer to Stefan", "snippet_date": "2025-02-13", "person_name": "Ludivine Flotte", "person_email": "ludivine.flotte@novartis.com", "internal_name": "Haosen Han; Tim Fung", "internal_email": "haosen@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=7d947fac82c4f42cb6a43e9642904a1d950c47ba13c035458cc2658a806029ce", "call_id": "2025-02-13_7d947fac82c4", "call_count": 1, "all_snippets": [{"quote": "I think what we have to do is just to wait for the brand team to answer to Stefan", "date": "2025-02-13", "callId": "2025-02-13_7d947fac82c4", "gongUrl": "https://app.gong.io/call?id=7d947fac82c4f42cb6a43e9642904a1d950c47ba13c035458cc2658a806029ce", "speakerId": "2371578451474048356", "customerName": "Ludivine Flotte", "internalName": "Haosen Han; Tim Fung", "customerEmail": "ludivine.flotte@novartis.com", "internalEmail": "haosen@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_prague_03f9b8d6", "company": "novartis", "gong_entity": "Prague", "gong_parent": "Novartis R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'll be in Prague, visiting the site in Prague.", "snippet_date": "2025-02-07", "person_name": "", "person_email": "linda.chin@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=f780f2fabe76e4160207b613012ddce01cbb414b99143d7a2643e28aa733d032", "call_id": "2025-02-07_f780f2fabe76", "call_count": 1, "all_snippets": [{"quote": "I'll be in Prague, visiting the site in Prague.", "date": "2025-02-07", "callId": "2025-02-07_f780f2fabe76", "gongUrl": "https://app.gong.io/call?id=f780f2fabe76e4160207b613012ddce01cbb414b99143d7a2643e28aa733d032", "speakerId": "3897084322689789499", "customerName": "", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_computational_aided_drug_discovery_8128e27e", "company": "novartis", "gong_entity": "Computational Aided Drug Discovery", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Yeah, it would be called computational aided drug discovery.", "snippet_date": "2025-01-31", "person_name": "Anna Bochicchio", "person_email": "anna.bochicchio@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "drug-discovery-ai", "manual_node_name": "AI for Drug Discovery", "manual_node_path": "Novartis Research & Development > Data & Digital Technology (R&D) > AI & Machine Learning > AI for Drug Discovery", "confidence": "medium", "reasoning": "Semantic match - computational aided drug discovery aligns with AI for drug discovery as both involve computational approaches to drug discovery"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=97c8992aafb0606ee6112290925d5808f8c44a468a39bd86a732816342550e40", "call_id": "2025-01-31_97c8992aafb0", "call_count": 1, "all_snippets": [{"quote": "Yeah, it would be called computational aided drug discovery.", "date": "2025-01-31", "callId": "2025-01-31_97c8992aafb0", "gongUrl": "https://app.gong.io/call?id=97c8992aafb0606ee6112290925d5808f8c44a468a39bd86a732816342550e40", "speakerId": "7330733733100790345", "customerName": "Anna Bochicchio", "internalName": "Jaden Dankevy", "customerEmail": "anna.bochicchio@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_field_medical_education_team_9a3159eb", "company": "novartis", "gong_entity": "Field Medical Education Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We are like five medical educators here in Mexico", "snippet_date": "2025-01-29", "person_name": "Dennis Cerrato", "person_email": "dennis.cerrato@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=63e8611ee363334b7f259adbcfd64b8e662b0e41438c3f1b48a85ebf74f7fb40", "call_id": "2025-01-29_63e8611ee363", "call_count": 1, "all_snippets": [{"quote": "We are like five medical educators here in Mexico", "date": "2025-01-29", "callId": "2025-01-29_63e8611ee363", "gongUrl": "https://app.gong.io/call?id=63e8611ee363334b7f259adbcfd64b8e662b0e41438c3f1b48a85ebf74f7fb40", "speakerId": "7287705195715936510", "customerName": "Dennis Cerrato", "internalName": "Jaden Dankevy", "customerEmail": "dennis.cerrato@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_car_t_c1d53160", "company": "novartis", "gong_entity": "CAR T", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So like the BP of CAR T", "snippet_date": "2025-01-23", "person_name": "Andrea Lopez; Andrea Lopez", "person_email": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "car-t-platform", "manual_node_name": "CAR-T Cell Therapy Platform", "manual_node_path": "Novartis Research & Development > Platform Technologies & Capabilities > CAR-T Cell Therapy Platform", "confidence": "high", "reasoning": "Exact acronym match - CAR T directly corresponds to CAR-T Cell Therapy Platform"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=1589b3e2489ee2516ed10da00f246bb45692d87cf6d04b749fb4ff5b63a0a2b3", "call_id": "2025-01-23_1589b3e2489e", "call_count": 1, "all_snippets": [{"quote": "So like the BP of CAR T", "date": "2025-01-23", "callId": "2025-01-23_1589b3e2489e", "gongUrl": "https://app.gong.io/call?id=1589b3e2489ee2516ed10da00f246bb45692d87cf6d04b749fb4ff5b63a0a2b3", "speakerId": "7344383228578123282", "customerName": "Andrea Lopez; Andrea Lopez", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_continuous_manufacturing_and_material_sciences_a0e1d744", "company": "novartis", "gong_entity": "Continuous Manufacturing and Material Sciences", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Like, so i will be part of continuous manufacturing and material sciences.", "snippet_date": "2025-01-13", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "call_id": "2025-01-13_6a9afd79e80c", "call_count": 1, "all_snippets": [{"quote": "Like, so i will be part of continuous manufacturing and material sciences.", "date": "2025-01-13", "callId": "2025-01-13_6a9afd79e80c", "gongUrl": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "speakerId": "7132722879719429782", "customerName": "Robert Szabo", "internalName": "Jaden Dankevy", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_statistical_and_analytical_development_84742777", "company": "novartis", "gong_entity": "Statistical and Analytical Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, right now, it's like material sciences is under, from statistical and analytical development.", "snippet_date": "2025-01-13", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-sciences-sm", "manual_node_name": "Analytical Sciences", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Analytical Sciences", "confidence": "medium", "reasoning": "Partial match - analytical development aligns with analytical sciences, though statistical component is not explicitly mentioned"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "call_id": "2025-01-13_6a9afd79e80c", "call_count": 1, "all_snippets": [{"quote": "So, right now, it's like material sciences is under, from statistical and analytical development.", "date": "2025-01-13", "callId": "2025-01-13_6a9afd79e80c", "gongUrl": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "speakerId": "7132722879719429782", "customerName": "Robert Szabo", "internalName": "Jaden Dankevy", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_material_sciences_e5af7775", "company": "novartis", "gong_entity": "Material Sciences", "gong_parent": "Statistical and Analytical Development", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then right now i'm in material sciences", "snippet_date": "2025-01-13", "person_name": "Robert Szabo", "person_email": "robert-1.szabo@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "call_id": "2025-01-13_6a9afd79e80c", "call_count": 1, "all_snippets": [{"quote": "And then right now i'm in material sciences", "date": "2025-01-13", "callId": "2025-01-13_6a9afd79e80c", "gongUrl": "https://app.gong.io/call?id=6a9afd79e80c237524c61b52ce86e6038ce8cab55d5cfb47ee572f13fe78a1ff", "speakerId": "7132722879719429782", "customerName": "Robert Szabo", "internalName": "Jaden Dankevy", "customerEmail": "robert-1.szabo@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_ctom_954c7423", "company": "novartis", "gong_entity": "CTOM", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Yeah, the CTOM, So CTOM.", "snippet_date": "2025-01-10", "person_name": "Andrea Lopez; Andrea Lopez", "person_email": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=e4f1c39631f6aef0211c0fd45bedf808cac4484f27e8c9b13510b84bdd8e54bf", "call_id": "2025-01-10_e4f1c39631f6", "call_count": 1, "all_snippets": [{"quote": "Yeah, the CTOM, So CTOM.", "date": "2025-01-10", "callId": "2025-01-10_e4f1c39631f6", "gongUrl": "https://app.gong.io/call?id=e4f1c39631f6aef0211c0fd45bedf808cac4484f27e8c9b13510b84bdd8e54bf", "speakerId": "6675217776239111794", "customerName": "Andrea Lopez; Andrea Lopez", "internalName": "Jaden Dankevy", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_scientific_research_center_97b9cbd0", "company": "novartis", "gong_entity": "Scientific Research Center", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "BioRender is mostly used by NIBR or Scientific Research Center", "snippet_date": "2025-01-10", "person_name": "Andrea Lopez; Andrea Lopez", "person_email": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "nibr-cambridge", "manual_node_name": "Novartis Institutes for BioMedical Research (NIBR) - Cambridge, MA", "manual_node_path": "Novartis Research & Development > Biomedical Research > Novartis Institutes for BioMedical Research (NIBR) - Cambridge, MA", "confidence": "medium", "reasoning": "Context mentions NIBR alongside Scientific Research Center, suggesting they may be referring to the same research institute or a related unit within NIBR"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=e4f1c39631f6aef0211c0fd45bedf808cac4484f27e8c9b13510b84bdd8e54bf", "call_id": "2025-01-10_e4f1c39631f6", "call_count": 1, "all_snippets": [{"quote": "BioRender is mostly used by NIBR or Scientific Research Center", "date": "2025-01-10", "callId": "2025-01-10_e4f1c39631f6", "gongUrl": "https://app.gong.io/call?id=e4f1c39631f6aef0211c0fd45bedf808cac4484f27e8c9b13510b84bdd8e54bf", "speakerId": "6675217776239111794", "customerName": "Andrea Lopez; Andrea Lopez", "internalName": "Jaden Dankevy", "customerEmail": "andrea-2.lopez@novartis.com; andrea-2.lopez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_gnf_228f8e8c", "company": "novartis", "gong_entity": "GNF", "gong_parent": "Novartis R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then there's some other sites, GNF in San Diego, and so on", "snippet_date": "2025-01-10", "person_name": "Samu Melkko", "person_email": "samu.melkko@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "call_id": "2025-01-10_5d15653f349d", "call_count": 1, "all_snippets": [{"quote": "And then there's some other sites, GNF in San Diego, and so on", "date": "2025-01-10", "callId": "2025-01-10_5d15653f349d", "gongUrl": "https://app.gong.io/call?id=5d15653f349d996cc5b49ac289c82e331df8445167f7a73e534e046c1bf4f1bc", "speakerId": "233530352534476423", "customerName": "Samu Melkko", "internalName": "Ross Proudfoot", "customerEmail": "samu.melkko@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_operations_department_c0df7bf0", "company": "novartis", "gong_entity": "Operations Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "In neuroscience, we have an operation operations department and that they are the one", "snippet_date": "2025-01-09", "person_name": "Magali Saint-Geniez; Magali Saint-Geniez", "person_email": "magali.saint-geniez@novartis.com; magali.saint-geniez@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "development-operations", "manual_node_name": "Development Operations", "manual_node_path": "Novartis Research & Development > Development > Development Operations", "confidence": "medium", "reasoning": "Context mentions neuroscience operations department, and Development Operations is the closest match for an operations-focused department in the org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=e4f629a603105a228bc73dbccbfdaffd25a88251115db8c7afb09dcd0de6cc87", "call_id": "2025-01-09_e4f629a60310", "call_count": 1, "all_snippets": [{"quote": "In neuroscience, we have an operation operations department and that they are the one", "date": "2025-01-09", "callId": "2025-01-09_e4f629a60310", "gongUrl": "https://app.gong.io/call?id=e4f629a603105a228bc73dbccbfdaffd25a88251115db8c7afb09dcd0de6cc87", "speakerId": "7744876303153779367", "customerName": "Magali Saint-Geniez; Magali Saint-Geniez", "internalName": "Jaden Dankevy", "customerEmail": "magali.saint-geniez@novartis.com; magali.saint-geniez@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_iam_team_389e4ef2", "company": "novartis", "gong_entity": "IAM Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We need to connect you with the IAM team because they will require certain details from you from your end as well, how to connect. And usually if you have those specs in a tech sheet available, I can see if we can do that per email. It's because you know, the whole team sits in India.", "snippet_date": "2024-12-13", "person_name": "Oswaldo Gonzalez", "person_email": "oswaldo.chavez_gonzalez@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=dd2cf5d634563379a31be9c05e8ea3e182634d50882d788f75c78d99c45146c2", "call_id": "2024-12-13_dd2cf5d63456", "call_count": 1, "all_snippets": [{"quote": "We need to connect you with the IAM team because they will require certain details from you from your end as well, how to connect. And usually if you have those specs in a tech sheet available, I can see if we can do that per email. It's because you know, the whole team sits in India.", "date": "2024-12-13", "callId": "2024-12-13_dd2cf5d63456", "gongUrl": "https://app.gong.io/call?id=dd2cf5d634563379a31be9c05e8ea3e182634d50882d788f75c78d99c45146c2", "speakerId": "8409960917617011566", "customerName": "Oswaldo Gonzalez", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "oswaldo.chavez_gonzalez@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_pre-clinical_safety_47c4344e", "company": "novartis", "gong_entity": "Pre-Clinical Safety", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "ive, recently started at novartis as of september this year and i joined in the team of pre clinical safety", "snippet_date": "2024-11-01", "person_name": "Battuja Dugershaw-Kurzer; Battuja Dugershaw-Kurzer", "person_email": "battuja.dugershaw-kurzer@novartis.com; battuja.dugershaw-kurzer@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-safety", "manual_node_name": "Clinical Safety", "manual_node_path": "Novartis Research & Development > Development > Clinical Pharmacology & Safety Sciences > Clinical Safety", "confidence": "medium", "reasoning": "Pre-clinical safety work would likely be closely related to the Clinical Safety team, though the naming suggests earlier stage safety assessment"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=83672da67963765369b5d7946a85f07dcbad7618edef1b58e2c4a3cc0f91ccb2", "call_id": "2024-11-01_83672da67963", "call_count": 1, "all_snippets": [{"quote": "ive, recently started at novartis as of september this year and i joined in the team of pre clinical safety", "date": "2024-11-01", "callId": "2024-11-01_83672da67963", "gongUrl": "https://app.gong.io/call?id=83672da67963765369b5d7946a85f07dcbad7618edef1b58e2c4a3cc0f91ccb2", "speakerId": "5400509824279603567", "customerName": "Battuja Dugershaw-Kurzer; Battuja Dugershaw-Kurzer", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "battuja.dugershaw-kurzer@novartis.com; battuja.dugershaw-kurzer@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_drug_disposition_cb1e762d", "company": "novartis", "gong_entity": "Drug Disposition", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "so this is the bigger department we had a drug disposition part so part of the pks science", "snippet_date": "2024-09-17", "person_name": "Ronja Wieboldt", "person_email": "ronja.wieboldt@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmacokinetics-pharmacodynamics", "manual_node_name": "Pharmacokinetics & Pharmacodynamics", "manual_node_path": "Novartis Research & Development > Development > Clinical Pharmacology & Safety Sciences > Pharmacokinetics & Pharmacodynamics", "confidence": "high", "reasoning": "Drug disposition is a core component of pharmacokinetics science, and the context mentions it as part of 'pks science' (pharmacokinetic science)"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2770f0ecf6caf8b6de4bf776d9b7be8c04d22191130420c7e858481c56dab11e", "call_id": "2024-09-17_2770f0ecf6ca", "call_count": 1, "all_snippets": [{"quote": "so this is the bigger department we had a drug disposition part so part of the pks science", "date": "2024-09-17", "callId": "2024-09-17_2770f0ecf6ca", "gongUrl": "https://app.gong.io/call?id=2770f0ecf6caf8b6de4bf776d9b7be8c04d22191130420c7e858481c56dab11e", "speakerId": "5164044134895614485", "customerName": "Ronja Wieboldt", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "ronja.wieboldt@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_pharmacokinetic_science_department_39189cb9", "company": "novartis", "gong_entity": "Pharmacokinetic Science Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of the pharmacokinetic science department", "snippet_date": "2024-08-27", "person_name": "Ronja Wieboldt", "person_email": "ronja.wieboldt@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmacokinetics-pharmacodynamics", "manual_node_name": "Pharmacokinetics & Pharmacodynamics", "manual_node_path": "Novartis Research & Development > Development > Clinical Pharmacology & Safety Sciences > Pharmacokinetics & Pharmacodynamics", "confidence": "high", "reasoning": "Direct semantic match - pharmacokinetic science aligns perfectly with the Pharmacokinetics & Pharmacodynamics team"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4375d20769b65204cb0dfb54ec56a57c1f9000b93a6ac64c7b397aa3ed63e2c8", "call_id": "2024-08-27_4375d20769b6", "call_count": 1, "all_snippets": [{"quote": "I'm part of the pharmacokinetic science department", "date": "2024-08-27", "callId": "2024-08-27_4375d20769b6", "gongUrl": "https://app.gong.io/call?id=4375d20769b65204cb0dfb54ec56a57c1f9000b93a6ac64c7b397aa3ed63e2c8", "speakerId": "8360743002449248083", "customerName": "Ronja Wieboldt", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "ronja.wieboldt@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_optimology_8938834c", "company": "novartis", "gong_entity": "Optimology", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "The ones that are not part of the central license is optimology, since they're closing their department at the end of may.", "snippet_date": "2024-05-17", "person_name": "Linda Chin", "person_email": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "ophthalmology-research", "manual_node_name": "Ophthalmology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Ophthalmology", "confidence": "medium", "reasoning": "Optimology appears to be a misspelling or alternate name for Ophthalmology, supported by context mentioning department closure which aligns with known Novartis ophthalmology restructuring"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "call_id": "2024-05-17_560cfd6973cd", "call_count": 1, "all_snippets": [{"quote": "The ones that are not part of the central license is optimology, since they're closing their department at the end of may.", "date": "2024-05-17", "callId": "2024-05-17_560cfd6973cd", "gongUrl": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "speakerId": "7443435717236899392", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_regenerative_diseases_77f48087", "company": "novartis", "gong_entity": "Regenerative Diseases", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I know you had optimology staying separate as well as engaging in regenerative diseases, staying separate.", "snippet_date": "2024-05-17", "person_name": "Linda Chin", "person_email": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "call_id": "2024-05-17_560cfd6973cd", "call_count": 1, "all_snippets": [{"quote": "I know you had optimology staying separate as well as engaging in regenerative diseases, staying separate.", "date": "2024-05-17", "callId": "2024-05-17_560cfd6973cd", "gongUrl": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "speakerId": "3977144156519309438", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_lab_ops_team_4b9b67a8", "company": "novartis", "gong_entity": "Lab Ops Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm on the lab ops team here in cambridge", "snippet_date": "2024-05-15", "person_name": "Nathalie Teissier; Nathalie Teissier", "person_email": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internal_name": "Linda Zeng; Ross Proudfoot", "internal_email": "linda.zeng@biorender.com; ross@biorender.com; lauren.lochtefeld@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-operations", "manual_node_name": "Clinical Operations", "manual_node_path": "Novartis Research & Development > Development > Development Operations > Clinical Operations", "confidence": "medium", "reasoning": "Lab operations team in Cambridge likely supports clinical operations activities, making Clinical Operations the closest organizational match"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=117cc5750d9eb41a1a0fd64fb1ffb2a51e0e4c9f6d4a2de60051e2ea30df027a", "call_id": "2024-05-15_117cc5750d9e", "call_count": 1, "all_snippets": [{"quote": "I'm on the lab ops team here in cambridge", "date": "2024-05-15", "callId": "2024-05-15_117cc5750d9e", "gongUrl": "https://app.gong.io/call?id=117cc5750d9eb41a1a0fd64fb1ffb2a51e0e4c9f6d4a2de60051e2ea30df027a", "speakerId": "7125152926124964504", "customerName": "Nathalie Teissier; Nathalie Teissier", "internalName": "Linda Zeng; Ross Proudfoot", "customerEmail": "nathalie.teissier@novartis.com; nathalie.teissier@novartis.com", "internalEmail": "linda.zeng@biorender.com; ross@biorender.com; lauren.lochtefeld@biorender.com", "sizeMentions": []}]}, {"id": "novartis_prc_department_d07f837d", "company": "novartis", "gong_entity": "PRC Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "there is the PRC department that a, that has to reduce the license numbers", "snippet_date": "2024-05-03", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Sandra Calles", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung; Walid Habboub", "internal_email": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=8c1f46a01b5433f73624cf6b7e5309c55e17dc1b572bf9c3e769bf038162c63d", "call_id": "2024-05-03_8c1f46a01b54", "call_count": 1, "all_snippets": [{"quote": "there is the PRC department that a, that has to reduce the license numbers", "date": "2024-05-03", "callId": "2024-05-03_8c1f46a01b54", "gongUrl": "https://app.gong.io/call?id=8c1f46a01b5433f73624cf6b7e5309c55e17dc1b572bf9c3e769bf038162c63d", "speakerId": "5231271707688761770", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Sandra Calles", "internalName": "Ross Proudfoot; Tim Fung; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_ph_department_eb50a5e4", "company": "novartis", "gong_entity": "PH Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "But there is also another one from the PH department that they are being placed completely", "snippet_date": "2024-05-03", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Sandra Calles", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung; Walid Habboub", "internal_email": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=8c1f46a01b5433f73624cf6b7e5309c55e17dc1b572bf9c3e769bf038162c63d", "call_id": "2024-05-03_8c1f46a01b54", "call_count": 1, "all_snippets": [{"quote": "But there is also another one from the PH department that they are being placed completely", "date": "2024-05-03", "callId": "2024-05-03_8c1f46a01b54", "gongUrl": "https://app.gong.io/call?id=8c1f46a01b5433f73624cf6b7e5309c55e17dc1b572bf9c3e769bf038162c63d", "speakerId": "5231271707688761770", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Sandra Calles", "internalName": "Ross Proudfoot; Tim Fung; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_bio_acid_development_6fcc6268", "company": "novartis", "gong_entity": "Bio Acid Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of bio acid development, one part of bios", "snippet_date": "2024-04-22", "person_name": "Rok Kosir", "person_email": "rok.kosir@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development", "manual_node_name": "Biologics Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development", "confidence": "medium", "reasoning": "Likely a mispronunciation or transcription error for 'Biologics Development' - the context of being 'part of bios' supports this match."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "call_id": "2024-04-22_c0f762e58a39", "call_count": 1, "all_snippets": [{"quote": "I'm part of bio acid development, one part of bios", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "910876744940341148", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_upstream_development_6ed4d047", "company": "novartis", "gong_entity": "Upstream Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "you have, you know, Upstream development, right", "snippet_date": "2024-04-22", "person_name": "Rok Kosir", "person_email": "rok.kosir@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-process-development", "manual_node_name": "Process Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development > Process Development", "confidence": "medium", "reasoning": "Upstream development is typically part of biologics process development, referring to cell culture and fermentation processes."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "call_id": "2024-04-22_c0f762e58a39", "call_count": 1, "all_snippets": [{"quote": "you have, you know, Upstream development, right", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "910876744940341148", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_drug_substance_development_32914f89", "company": "novartis", "gong_entity": "Drug Substance Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "you have drug substance development", "snippet_date": "2024-04-22", "person_name": "Rok Kosir", "person_email": "rok.kosir@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "small-molecule-development", "manual_node_name": "Small Molecule Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development", "confidence": "medium", "reasoning": "Drug substance development is a core function within small molecule development, focusing on API development and manufacturing."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "call_id": "2024-04-22_c0f762e58a39", "call_count": 1, "all_snippets": [{"quote": "you have drug substance development", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "910876744940341148", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_drug_product_development_6df267b3", "company": "novartis", "gong_entity": "Drug Product Development", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "you have drug product development", "snippet_date": "2024-04-22", "person_name": "Rok Kosir", "person_email": "rok.kosir@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-development", "manual_node_name": "Pharmaceutical Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Pharmaceutical Development", "confidence": "high", "reasoning": "Drug product development is essentially pharmaceutical development - formulation and final dosage form development."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "call_id": "2024-04-22_c0f762e58a39", "call_count": 1, "all_snippets": [{"quote": "you have drug product development", "date": "2024-04-22", "callId": "2024-04-22_c0f762e58a39", "gongUrl": "https://app.gong.io/call?id=c0f762e58a39d3de6c30775971c342863768b1c3ae298e2b92b35af78c994d9e", "speakerId": "910876744940341148", "customerName": "Rok Kosir", "internalName": "Jaden Dankevy", "customerEmail": "rok.kosir@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biomedical_research_community_c075bccc", "company": "novartis", "gong_entity": "Biomedical Research Community", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "I give talks to the whole biomedical research community sometimes", "snippet_date": "2024-04-12", "person_name": "Isra Hassan", "person_email": "isra.hassan@novartis.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "high", "reasoning": "Direct match - refers to the broader biomedical research division and its community of researchers."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=788bb75f3765993a8feaa37fbad3a1531821c841cf69140c41e7b10e7d3dee03", "call_id": "2024-04-12_788bb75f3765", "call_count": 1, "all_snippets": [{"quote": "I give talks to the whole biomedical research community sometimes", "date": "2024-04-12", "callId": "2024-04-12_788bb75f3765", "gongUrl": "https://app.gong.io/call?id=788bb75f3765993a8feaa37fbad3a1531821c841cf69140c41e7b10e7d3dee03", "speakerId": "1149972359536490699", "customerName": "Isra Hassan", "internalName": "Jaden Dankevy", "customerEmail": "isra.hassan@novartis.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": []}]}, {"id": "novartis_novartis_gene_therapies_adf19ef4", "company": "novartis", "gong_entity": "Novartis Gene Therapies", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm working in novartis Gene therapies", "snippet_date": "2024-04-09", "person_name": "S\u00e9bastien Reig", "person_email": "seabstien.reig@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "gene-therapy-platform", "manual_node_name": "Gene Therapy Platform", "manual_node_path": "Novartis Research & Development > Platform Technologies & Capabilities > Gene Therapy Platform", "confidence": "medium", "reasoning": "Likely refers to the gene therapy platform department, though could also relate to gene therapy manufacturing or development functions."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=0188070f4c6c0983d3447b5197ab58952248956c988996fec0e1e10490561c37", "call_id": "2024-04-09_0188070f4c6c", "call_count": 1, "all_snippets": [{"quote": "I'm working in novartis Gene therapies", "date": "2024-04-09", "callId": "2024-04-09_0188070f4c6c", "gongUrl": "https://app.gong.io/call?id=0188070f4c6c0983d3447b5197ab58952248956c988996fec0e1e10490561c37", "speakerId": "8465446700013931599", "customerName": "S\u00e9bastien Reig", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "seabstien.reig@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_gene_therapies_group_35d526f0", "company": "novartis", "gong_entity": "Gene Therapies Group", "gong_parent": "Novartis Gene Therapies", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "There's a biologic group, a Gene therapies group", "snippet_date": "2024-05-17", "person_name": "Linda Chin", "person_email": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internal_name": "Ross Proudfoot; Tim Fung", "internal_email": "ross@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "gene-therapy-platform", "manual_node_name": "Gene Therapy Platform", "manual_node_path": "Novartis Research & Development > Platform Technologies & Capabilities > Gene Therapy Platform", "confidence": "medium", "reasoning": "Best match for a gene therapies group would be the Gene Therapy Platform department, though the entity suggests a team-level organization."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "call_id": "2024-05-17_560cfd6973cd", "call_count": 1, "all_snippets": [{"quote": "There's a biologic group, a Gene therapies group", "date": "2024-05-17", "callId": "2024-05-17_560cfd6973cd", "gongUrl": "https://app.gong.io/call?id=560cfd6973cd03bf07abb480af73200da4cd1c7c3e21b1ed190e43d4b54d4a60", "speakerId": "3977144156519309438", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Tim Fung", "customerEmail": "linda.chin@novartis.com; adam.tomaszewski@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; tim@biorender.com", "sizeMentions": []}]}, {"id": "novartis_medical_affair_team_eb16c623", "company": "novartis", "gong_entity": "Medical Affair Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "novartis in my medical affair team doesn't have an agreement, doesn't have a license", "snippet_date": "2024-04-09", "person_name": "S\u00e9bastien Reig", "person_email": "seabstien.reig@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0188070f4c6c0983d3447b5197ab58952248956c988996fec0e1e10490561c37", "call_id": "2024-04-09_0188070f4c6c", "call_count": 1, "all_snippets": [{"quote": "novartis in my medical affair team doesn't have an agreement, doesn't have a license", "date": "2024-04-09", "callId": "2024-04-09_0188070f4c6c", "gongUrl": "https://app.gong.io/call?id=0188070f4c6c0983d3447b5197ab58952248956c988996fec0e1e10490561c37", "speakerId": "8465446700013931599", "customerName": "S\u00e9bastien Reig", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "seabstien.reig@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_discovery_95ec8eaa", "company": "novartis", "gong_entity": "Discovery", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "One is discovery, which is totally like an academic organization", "snippet_date": "2024-03-27", "person_name": "Prateek Tripathi", "person_email": "prateek.tripathi@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "medium", "reasoning": "Discovery activities typically fall under biomedical research division, though no exact 'Discovery' department exists in the org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "call_id": "2024-03-27_855f773b00e5", "call_count": 1, "all_snippets": [{"quote": "One is discovery, which is totally like an academic organization", "date": "2024-03-27", "callId": "2024-03-27_855f773b00e5", "gongUrl": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "speakerId": "171743836081310569", "customerName": "Prateek Tripathi", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "prateek.tripathi@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_gene_therapies_e81ec8a9", "company": "novartis", "gong_entity": "Gene Therapies", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we are pre of what I sell in Gene therapies, we only focus on\u2026 the portfolio related with selling Gene therapy", "snippet_date": "2024-03-27", "person_name": "Prateek Tripathi", "person_email": "prateek.tripathi@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "gene-therapy-platform", "manual_node_name": "Gene Therapy Platform", "manual_node_path": "Novartis Research & Development > Platform Technologies & Capabilities > Gene Therapy Platform", "confidence": "high", "reasoning": "Direct semantic match - Gene Therapies aligns with Gene Therapy Platform department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "call_id": "2024-03-27_855f773b00e5", "call_count": 1, "all_snippets": [{"quote": "So we are pre of what I sell in Gene therapies, we only focus on\u2026 the portfolio related with selling Gene therapy", "date": "2024-03-27", "callId": "2024-03-27_855f773b00e5", "gongUrl": "https://app.gong.io/call?id=855f773b00e5a1d1e66371da28603edd9ea8a4fce63493d0b69c4efd0a8a57cb", "speakerId": "171743836081310569", "customerName": "Prateek Tripathi", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "prateek.tripathi@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_itt_0c622372", "company": "novartis", "gong_entity": "ITT", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I've been in the group originally was called it and T, which was like innovative targets and technology", "snippet_date": "2024-03-26", "person_name": "Adam Selsman", "person_email": "adam.selsman@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=fbdc350996b304f75b9420abf8114a4961024616d8915f5c192ea7e6812d35bb", "call_id": "2024-03-26_fbdc350996b3", "call_count": 1, "all_snippets": [{"quote": "I've been in the group originally was called it and T, which was like innovative targets and technology", "date": "2024-03-26", "callId": "2024-03-26_fbdc350996b3", "gongUrl": "https://app.gong.io/call?id=fbdc350996b304f75b9420abf8114a4961024616d8915f5c192ea7e6812d35bb", "speakerId": "265226681575311336", "customerName": "Adam Selsman", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "adam.selsman@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_t_bad_dbc47590", "company": "novartis", "gong_entity": "T BAD", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We shifted our name to T bad", "snippet_date": "2024-03-26", "person_name": "Adam Selsman", "person_email": "adam.selsman@novartis.com", "internal_name": "Jaden Dankevy; Ross Proudfoot", "internal_email": "jaden.dankevy@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=fbdc350996b304f75b9420abf8114a4961024616d8915f5c192ea7e6812d35bb", "call_id": "2024-03-26_fbdc350996b3", "call_count": 1, "all_snippets": [{"quote": "We shifted our name to T bad", "date": "2024-03-26", "callId": "2024-03-26_fbdc350996b3", "gongUrl": "https://app.gong.io/call?id=fbdc350996b304f75b9420abf8114a4961024616d8915f5c192ea7e6812d35bb", "speakerId": "265226681575311336", "customerName": "Adam Selsman", "internalName": "Jaden Dankevy; Ross Proudfoot", "customerEmail": "adam.selsman@novartis.com", "internalEmail": "jaden.dankevy@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_data_stewards_team_7094f773", "company": "novartis", "gong_entity": "Data Stewards Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "to find someone that the data stewards team, that they can tweak the system and the database manually", "snippet_date": "2024-03-15", "person_name": "Linda Chin", "person_email": "linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internal_name": "Ross Proudfoot; Walid Habboub", "internal_email": "ross@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-data-management", "manual_node_name": "Clinical Data Management", "manual_node_path": "Novartis Research & Development > Development > Development Operations > Clinical Data Management", "confidence": "medium", "reasoning": "Data stewards would likely be part of clinical data management operations, though not an exact match"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4748cb449844560c3b8460da54485ddc91666dc743f7c2e0711313d49eb94971", "call_id": "2024-03-15_4748cb449844", "call_count": 1, "all_snippets": [{"quote": "to find someone that the data stewards team, that they can tweak the system and the database manually", "date": "2024-03-15", "callId": "2024-03-15_4748cb449844", "gongUrl": "https://app.gong.io/call?id=4748cb449844560c3b8460da54485ddc91666dc743f7c2e0711313d49eb94971", "speakerId": "2139737997158222790", "customerName": "Linda Chin", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "linda.chin@novartis.com; sandra.calles@novartis.com; carlos-2.lopez_ext@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_br_division_de2f30ca", "company": "novartis", "gong_entity": "BR Division", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "first scientific department within the BR division, the biometric research", "snippet_date": "2024-03-01", "person_name": "Adam; Carlos-2 Lopez; Linda Chin; Marion Wiesmann; Petra Simic; Stefan Melly", "person_email": "adam.tomaszewski@novartis.com; carlos-2.lopez_ext@novartis.com; linda.chin@novartis.com; marion.wiesmann@novartis.com; petra.simic@novartis.com; stefan.melly@novartis.com; sandra.calles@novartis.com", "internal_name": "Ross Proudfoot; Walid Habboub", "internal_email": "ross@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "medium", "reasoning": "BR likely stands for Biomedical Research division based on context"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7b31b87ac1bd97c480914d2a3847bec6652478931e5b2f06276fa50103a7fb6e", "call_id": "2024-03-01_7b31b87ac1bd", "call_count": 1, "all_snippets": [{"quote": "first scientific department within the BR division, the biometric research", "date": "2024-03-01", "callId": "2024-03-01_7b31b87ac1bd", "gongUrl": "https://app.gong.io/call?id=7b31b87ac1bd97c480914d2a3847bec6652478931e5b2f06276fa50103a7fb6e", "speakerId": "6550203676745257136", "customerName": "Adam; Carlos-2 Lopez; Linda Chin; Marion Wiesmann; Petra Simic; Stefan Melly", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; carlos-2.lopez_ext@novartis.com; linda.chin@novartis.com; marion.wiesmann@novartis.com; petra.simic@novartis.com; stefan.melly@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biologic_department_1d6dc131", "company": "novartis", "gong_entity": "Biologic Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm taking care of the biologic department which is, in the us and in Switzerland", "snippet_date": "2024-03-01", "person_name": "Adam; Carlos-2 Lopez; Linda Chin; Marion Wiesmann; Petra Simic; Stefan Melly", "person_email": "adam.tomaszewski@novartis.com; carlos-2.lopez_ext@novartis.com; linda.chin@novartis.com; marion.wiesmann@novartis.com; petra.simic@novartis.com; stefan.melly@novartis.com; sandra.calles@novartis.com", "internal_name": "Ross Proudfoot; Walid Habboub", "internal_email": "ross@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development", "manual_node_name": "Biologics Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development", "confidence": "high", "reasoning": "Direct match - Biologic Department aligns with Biologics Development department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7b31b87ac1bd97c480914d2a3847bec6652478931e5b2f06276fa50103a7fb6e", "call_id": "2024-03-01_7b31b87ac1bd", "call_count": 1, "all_snippets": [{"quote": "I'm taking care of the biologic department which is, in the us and in Switzerland", "date": "2024-03-01", "callId": "2024-03-01_7b31b87ac1bd", "gongUrl": "https://app.gong.io/call?id=7b31b87ac1bd97c480914d2a3847bec6652478931e5b2f06276fa50103a7fb6e", "speakerId": "6550203676745257136", "customerName": "Adam; Carlos-2 Lopez; Linda Chin; Marion Wiesmann; Petra Simic; Stefan Melly", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; carlos-2.lopez_ext@novartis.com; linda.chin@novartis.com; marion.wiesmann@novartis.com; petra.simic@novartis.com; stefan.melly@novartis.com; sandra.calles@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_analytics_department_d75bf50b", "company": "novartis", "gong_entity": "Analytics Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": "60", "confidence": "high", "mention_count": 1, "snippet": "I work in analytics department, so it's a technical research and development. So, I have a group of eight people, but we are cooperating a lot with also the Basel folk. So altogether in analytics, there's like approximately 50 to 60 members, some senior, some associate experts.", "snippet_date": "2024-02-20", "person_name": "Davor Obradovic", "person_email": "davor.obradovic@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-sciences-sm", "manual_node_name": "Analytical Sciences", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Small Molecule Development > Analytical Sciences", "confidence": "medium", "reasoning": "Analytics Department likely refers to Analytical Sciences, though there are multiple analytical teams in the org"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=56aed2d864477a227556448ee58e819d5ac362ae15fd23445426b1f60e093b93", "call_id": "2024-02-20_56aed2d86447", "call_count": 1, "all_snippets": [{"quote": "I work in analytics department, so it's a technical research and development. So, I have a group of eight people, but we are cooperating a lot with also the Basel folk. So altogether in analytics, there's like approximately 50 to 60 members, some senior, some associate experts.", "date": "2024-02-20", "callId": "2024-02-20_56aed2d86447", "gongUrl": "https://app.gong.io/call?id=56aed2d864477a227556448ee58e819d5ac362ae15fd23445426b1f60e093b93", "speakerId": "4231809808949283905", "customerName": "Davor Obradovic", "internalName": "Ross Proudfoot", "customerEmail": "davor.obradovic@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": [{"value": "60", "snippetIndex": 0, "source": {"callDate": "2024-02-20", "customerName": "Davor Obradovic"}}]}]}, {"id": "novartis_medical_team_6cdea7ec", "company": "novartis", "gong_entity": "Medical Team", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of a team of five of us and it's a very new program, part of, a, sorry, I don't think I've ever said it in English. Mexico. We're located in Mexico and basically, we are a new area part of the medical team", "snippet_date": "2024-02-08", "person_name": "Elsie Gonzalez; Elsie Gonzalez", "person_email": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "call_id": "2024-02-08_af0e68dc4453", "call_count": 1, "all_snippets": [{"quote": "I'm part of a team of five of us and it's a very new program, part of, a, sorry, I don't think I've ever said it in English. Mexico. We're located in Mexico and basically, we are a new area part of the medical team", "date": "2024-02-08", "callId": "2024-02-08_af0e68dc4453", "gongUrl": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "speakerId": "8052422846018822405", "customerName": "Elsie Gonzalez; Elsie Gonzalez", "internalName": "Ross Proudfoot", "customerEmail": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_hematology_802e762d", "company": "novartis", "gong_entity": "Hematology", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I've been assigned the therapeutic areas of chematology and\u2026 chemotology, and neurology", "snippet_date": "2024-02-08", "person_name": "Elsie Gonzalez; Elsie Gonzalez", "person_email": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "hematologic-malignancies", "manual_node_name": "Hematologic Malignancies", "manual_node_path": "Novartis Research & Development > Biomedical Research > Oncology Research > Hematologic Malignancies", "confidence": "high", "reasoning": "Direct semantic match - Hematology therapeutic area aligns with Hematologic Malignancies team"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "call_id": "2024-02-08_af0e68dc4453", "call_count": 1, "all_snippets": [{"quote": "I've been assigned the therapeutic areas of chematology and\u2026 chemotology, and neurology", "date": "2024-02-08", "callId": "2024-02-08_af0e68dc4453", "gongUrl": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "speakerId": "8052422846018822405", "customerName": "Elsie Gonzalez; Elsie Gonzalez", "internalName": "Ross Proudfoot", "customerEmail": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_neurology_cbc1a469", "company": "novartis", "gong_entity": "Neurology", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I've been assigned the therapeutic areas of chematology and\u2026 chemotology, and neurology", "snippet_date": "2024-02-08", "person_name": "Elsie Gonzalez; Elsie Gonzalez", "person_email": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "neuroscience-research", "manual_node_name": "Neuroscience", "manual_node_path": "Novartis Research & Development > Biomedical Research > Neuroscience", "confidence": "medium", "reasoning": "Neurology is closely related to Neuroscience therapeutic area, though not an exact match. Both deal with nervous system disorders."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "call_id": "2024-02-08_af0e68dc4453", "call_count": 1, "all_snippets": [{"quote": "I've been assigned the therapeutic areas of chematology and\u2026 chemotology, and neurology", "date": "2024-02-08", "callId": "2024-02-08_af0e68dc4453", "gongUrl": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "speakerId": "8052422846018822405", "customerName": "Elsie Gonzalez; Elsie Gonzalez", "internalName": "Ross Proudfoot", "customerEmail": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_cardio_d2aba7cc", "company": "novartis", "gong_entity": "Cardio", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "However, my coworkers are working on immunology\u2026 oncology and, cardio, right?", "snippet_date": "2024-02-08", "person_name": "Elsie Gonzalez; Elsie Gonzalez", "person_email": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "cardiovascular-renal-metabolic", "manual_node_name": "Cardiovascular, Renal & Metabolic Diseases", "manual_node_path": "Novartis Research & Development > Biomedical Research > Cardiovascular, Renal & Metabolic Diseases", "confidence": "high", "reasoning": "Cardio is a clear abbreviation for Cardiovascular, matching the therapeutic area exactly."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "call_id": "2024-02-08_af0e68dc4453", "call_count": 1, "all_snippets": [{"quote": "However, my coworkers are working on immunology\u2026 oncology and, cardio, right?", "date": "2024-02-08", "callId": "2024-02-08_af0e68dc4453", "gongUrl": "https://app.gong.io/call?id=af0e68dc4453e730c5fed1e64dcbea09d570f40970722a0c7508ee2cf5653141", "speakerId": "8052422846018822405", "customerName": "Elsie Gonzalez; Elsie Gonzalez", "internalName": "Ross Proudfoot", "customerEmail": "elsie.gonz@novartis.com; elsie.gonz@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_translational_profiling_4f8c553f", "company": "novartis", "gong_entity": "Translational Profiling", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "where in translational profiling that's another team", "snippet_date": "2023-12-05", "person_name": "Alexandre Bouzekri; Alexandre Bouzekri; Wendy Fantl; Wendy Fantl", "person_email": "alexandre.bouzekri@novartis.com; alexandre.bouzekri@novartis.com; wendy-1.fantl@novartis.com; wendy-1.fantl@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "translational-medicine", "manual_node_name": "Translational Medicine", "manual_node_path": "Novartis Research & Development > Development > Translational Medicine", "confidence": "medium", "reasoning": "Translational Profiling appears to be a team within the broader Translational Medicine department, though not an exact match."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=59d91af76958d0ab95d7b81c80260cdc2293587cf0d4e10e20a2b31887470dbd", "call_id": "2023-12-05_59d91af76958", "call_count": 1, "all_snippets": [{"quote": "where in translational profiling that's another team", "date": "2023-12-05", "callId": "2023-12-05_59d91af76958", "gongUrl": "https://app.gong.io/call?id=59d91af76958d0ab95d7b81c80260cdc2293587cf0d4e10e20a2b31887470dbd", "speakerId": "4580508943786755568", "customerName": "Alexandre Bouzekri; Alexandre Bouzekri; Wendy Fantl; Wendy Fantl", "internalName": "Ross Proudfoot", "customerEmail": "alexandre.bouzekri@novartis.com; alexandre.bouzekri@novartis.com; wendy-1.fantl@novartis.com; wendy-1.fantl@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biomedical_research_group_4219c3a8", "company": "novartis", "gong_entity": "Biomedical Research Group", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we are in the preclinical safety department, also in the biomedical research group.", "snippet_date": "2023-10-27", "person_name": "Hannah Morgan; Hannah Morgan", "person_email": "hannah.morgan@novartis.com; hannah.morgan@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "high", "reasoning": "Exact match - Biomedical Research Group corresponds to the Biomedical Research division."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=3cedba2fefd3a406e7bd06e34eef100c35f74dd289ffdd44949e6c7540ba4af2", "call_id": "2023-10-27_3cedba2fefd3", "call_count": 1, "all_snippets": [{"quote": "So we are in the preclinical safety department, also in the biomedical research group.", "date": "2023-10-27", "callId": "2023-10-27_3cedba2fefd3", "gongUrl": "https://app.gong.io/call?id=3cedba2fefd3a406e7bd06e34eef100c35f74dd289ffdd44949e6c7540ba4af2", "speakerId": "3931876449247561799", "customerName": "Hannah Morgan; Hannah Morgan", "internalName": "Ross Proudfoot", "customerEmail": "hannah.morgan@novartis.com; hannah.morgan@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_preclinical_safety_department_6b90212d", "company": "novartis", "gong_entity": "Preclinical Safety Department", "gong_parent": "Biomedical Research Group", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we are in the preclinical safety department, also in the biomedical research group.", "snippet_date": "2023-10-27", "person_name": "Hannah Morgan; Hannah Morgan", "person_email": "hannah.morgan@novartis.com; hannah.morgan@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-pharmacology-safety-sciences", "manual_node_name": "Clinical Pharmacology & Safety Sciences", "manual_node_path": "Novartis Research & Development > Development > Clinical Pharmacology & Safety Sciences", "confidence": "medium", "reasoning": "Preclinical Safety would logically fall under the broader Clinical Pharmacology & Safety Sciences department, though not an exact match."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=3cedba2fefd3a406e7bd06e34eef100c35f74dd289ffdd44949e6c7540ba4af2", "call_id": "2023-10-27_3cedba2fefd3", "call_count": 1, "all_snippets": [{"quote": "So we are in the preclinical safety department, also in the biomedical research group.", "date": "2023-10-27", "callId": "2023-10-27_3cedba2fefd3", "gongUrl": "https://app.gong.io/call?id=3cedba2fefd3a406e7bd06e34eef100c35f74dd289ffdd44949e6c7540ba4af2", "speakerId": "3931876449247561799", "customerName": "Hannah Morgan; Hannah Morgan", "internalName": "Ross Proudfoot", "customerEmail": "hannah.morgan@novartis.com; hannah.morgan@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_it_department_a6e0fbc6", "company": "novartis", "gong_entity": "IT Department", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "The owners of the money usually sit within our it department", "snippet_date": "2023-10-26", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Noethiger, Michael (Ext); TARHINI", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; michael.noethiger@novartis.com; walid.tarhini@novartis.com", "internal_name": "Ross Proudfoot; Walid Habboub", "internal_email": "ross@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "data-digital-technology", "manual_node_name": "Data & Digital Technology (R&D)", "manual_node_path": "Novartis Research & Development > Data & Digital Technology (R&D)", "confidence": "medium", "reasoning": "IT Department likely corresponds to the Data & Digital Technology division, though the naming differs."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b1a7b65ba086bc7fff79614c21f35b52c27ba660d36ba4ee6ee0e9315187ed27", "call_id": "2023-10-26_b1a7b65ba086", "call_count": 1, "all_snippets": [{"quote": "The owners of the money usually sit within our it department", "date": "2023-10-26", "callId": "2023-10-26_b1a7b65ba086", "gongUrl": "https://app.gong.io/call?id=b1a7b65ba086bc7fff79614c21f35b52c27ba660d36ba4ee6ee0e9315187ed27", "speakerId": "3932232304003328808", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Noethiger, Michael (Ext); TARHINI", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; michael.noethiger@novartis.com; walid.tarhini@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_adaptive_ology_a9a275a4", "company": "novartis", "gong_entity": "Adaptive Ology", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, adaptive ology has recently brought on a group licensing purchase through BioRender.", "snippet_date": "2023-10-06", "person_name": "Adam; Adam; Petra Simic", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; petra.simic@novartis.com", "internal_name": "Ross Proudfoot; Walid Habboub", "internal_email": "ross@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=c6587a1bc0b6fb42e5da665c0b932422bfb43fe9a60db14c14f4882774b74ed5", "call_id": "2023-10-06_c6587a1bc0b6", "call_count": 1, "all_snippets": [{"quote": "So, adaptive ology has recently brought on a group licensing purchase through BioRender.", "date": "2023-10-06", "callId": "2023-10-06_c6587a1bc0b6", "gongUrl": "https://app.gong.io/call?id=c6587a1bc0b6fb42e5da665c0b932422bfb43fe9a60db14c14f4882774b74ed5", "speakerId": "1388177930282429252", "customerName": "Adam; Adam; Petra Simic", "internalName": "Ross Proudfoot; Walid Habboub", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; petra.simic@novartis.com", "internalEmail": "ross@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "novartis_adaptive_immunity_group_7a095812", "company": "novartis", "gong_entity": "Adaptive Immunity Group", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "With, with Thomas's adaptive immunity group that has five licenses", "snippet_date": "2023-08-28", "person_name": "Bruno Cenni; Tomaszewski, Adam", "person_email": "bruno.cenni@novartis.com; adam.tomaszewski@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "immunology-research", "manual_node_name": "Immunology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Immunology", "confidence": "medium", "reasoning": "Adaptive Immunity Group would logically fall under the broader Immunology therapeutic area, focusing on adaptive immune responses."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b782d3d17ed2662bccd400cc93397332a88a81dbaec4be106de436e3b84142d7", "call_id": "2023-08-28_b782d3d17ed2", "call_count": 1, "all_snippets": [{"quote": "With, with Thomas's adaptive immunity group that has five licenses", "date": "2023-08-28", "callId": "2023-08-28_b782d3d17ed2", "gongUrl": "https://app.gong.io/call?id=b782d3d17ed2662bccd400cc93397332a88a81dbaec4be106de436e3b84142d7", "speakerId": "7961968164994416683", "customerName": "Bruno Cenni; Tomaszewski, Adam", "internalName": "Ross Proudfoot", "customerEmail": "bruno.cenni@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_immunology_group_4b04b184", "company": "novartis", "gong_entity": "Immunology Group", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I think, if that were possible to have an immunology group?", "snippet_date": "2023-08-28", "person_name": "Bruno Cenni; Tomaszewski, Adam", "person_email": "bruno.cenni@novartis.com; adam.tomaszewski@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "immunology-research", "manual_node_name": "Immunology", "manual_node_path": "Novartis Research & Development > Biomedical Research > Immunology", "confidence": "high", "reasoning": "Direct match - Immunology Group corresponds to the Immunology therapeutic area."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b782d3d17ed2662bccd400cc93397332a88a81dbaec4be106de436e3b84142d7", "call_id": "2023-08-28_b782d3d17ed2", "call_count": 1, "all_snippets": [{"quote": "So I think, if that were possible to have an immunology group?", "date": "2023-08-28", "callId": "2023-08-28_b782d3d17ed2", "gongUrl": "https://app.gong.io/call?id=b782d3d17ed2662bccd400cc93397332a88a81dbaec4be106de436e3b84142d7", "speakerId": "7961968164994416683", "customerName": "Bruno Cenni; Tomaszewski, Adam", "internalName": "Ross Proudfoot", "customerEmail": "bruno.cenni@novartis.com; adam.tomaszewski@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_london_12bc95fc", "company": "novartis", "gong_entity": "London", "gong_parent": "Novartis R&D", "entity_type": "site", "team_size": "26", "confidence": "high", "mention_count": 1, "snippet": "another 26 over in London", "snippet_date": "2023-06-21", "person_name": "Charles Banos", "person_email": "charles.banos@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=3d6910a4f00319fb274790f8b9291ba4029ac504b15142592b859aef6dd89549", "call_id": "2023-06-21_3d6910a4f003", "call_count": 1, "all_snippets": [{"quote": "another 26 over in London", "date": "2023-06-21", "callId": "2023-06-21_3d6910a4f003", "gongUrl": "https://app.gong.io/call?id=3d6910a4f00319fb274790f8b9291ba4029ac504b15142592b859aef6dd89549", "speakerId": "6458267621969453639", "customerName": "Charles Banos", "internalName": "Ross Proudfoot", "customerEmail": "charles.banos@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_rp_group_b53b17e7", "company": "novartis", "gong_entity": "RP Group", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": "20", "confidence": "high", "mention_count": 1, "snippet": "We have seven lab heads in the RP group. So the principal investigators and then every investigator has two, three or four research associates. So people in the lab. So overall, we are 20\u2026 I think at the moment", "snippet_date": "2023-05-26", "person_name": "Agnieszka Kabat", "person_email": "aga.kabat@novartis.com", "internal_name": "Timothy Fung", "internal_email": "tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=57f3ca0e09057b043e8e164ffdd0bde57c28b64e0135ed7d3e3fa21146c7d2d5", "call_id": "2023-05-26_57f3ca0e0905", "call_count": 1, "all_snippets": [{"quote": "We have seven lab heads in the RP group. So the principal investigators and then every investigator has two, three or four research associates. So people in the lab. So overall, we are 20\u2026 I think at the moment", "date": "2023-05-26", "callId": "2023-05-26_57f3ca0e0905", "gongUrl": "https://app.gong.io/call?id=57f3ca0e09057b043e8e164ffdd0bde57c28b64e0135ed7d3e3fa21146c7d2d5", "speakerId": "2481424872608103017", "customerName": "Agnieszka Kabat", "internalName": "Timothy Fung", "customerEmail": "aga.kabat@novartis.com", "internalEmail": "tim@biorender.com", "sizeMentions": [{"value": "20", "snippetIndex": 0, "source": {"callDate": "2023-05-26", "customerName": "Agnieszka Kabat"}}]}]}, {"id": "novartis_oncology_translational_research_04b04c25", "company": "novartis", "gong_entity": "Oncology Translational Research", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we are group within oncology translational research", "snippet_date": "2023-05-15", "person_name": "Nadia Hassounah", "person_email": "nadia.hassounah@novartis.com", "internal_name": "Julia Coupland; Ross Proudfoot", "internal_email": "julia@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "translational-medicine", "manual_node_name": "Translational Medicine", "manual_node_path": "Novartis Research & Development > Development > Translational Medicine", "confidence": "medium", "reasoning": "Strong semantic match - entity mentions being within 'oncology translational research' which aligns with the Translational Medicine department that focuses on bridging research and development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=834463ba859fdc25932eb4580c1c5cca1d1907b5eccc809914809949a9749922", "call_id": "2023-05-15_834463ba859f", "call_count": 1, "all_snippets": [{"quote": "we are group within oncology translational research", "date": "2023-05-15", "callId": "2023-05-15_834463ba859f", "gongUrl": "https://app.gong.io/call?id=834463ba859fdc25932eb4580c1c5cca1d1907b5eccc809914809949a9749922", "speakerId": "3141364032382923138", "customerName": "Nadia Hassounah", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "nadia.hassounah@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_autoimmune_disease_area_fcc0b415", "company": "novartis", "gong_entity": "Autoimmune Disease Area", "gong_parent": "Novartis R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "there's a group not in my department but sort of like merging immunity. So autoimmune disease area and some oncology work", "snippet_date": "2023-05-15", "person_name": "Nadia Hassounah", "person_email": "nadia.hassounah@novartis.com", "internal_name": "Julia Coupland; Ross Proudfoot", "internal_email": "julia@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "autoimmune-diseases", "manual_node_name": "Autoimmune Diseases", "manual_node_path": "Novartis Research & Development > Biomedical Research > Immunology > Autoimmune Diseases", "confidence": "high", "reasoning": "Exact semantic match - 'Autoimmune Disease Area' directly corresponds to the 'Autoimmune Diseases' team under Immunology research"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=834463ba859fdc25932eb4580c1c5cca1d1907b5eccc809914809949a9749922", "call_id": "2023-05-15_834463ba859f", "call_count": 1, "all_snippets": [{"quote": "there's a group not in my department but sort of like merging immunity. So autoimmune disease area and some oncology work", "date": "2023-05-15", "callId": "2023-05-15_834463ba859f", "gongUrl": "https://app.gong.io/call?id=834463ba859fdc25932eb4580c1c5cca1d1907b5eccc809914809949a9749922", "speakerId": "3141364032382923138", "customerName": "Nadia Hassounah", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "nadia.hassounah@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_demand_qualification_service_7d357336", "company": "novartis", "gong_entity": "Demand Qualification Service", "gong_parent": "Novartis R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Now, at the moment, it comes to me, I'm running a call of the demand qualification service where I collect all the software requirements.", "snippet_date": "2023-05-03", "person_name": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Safia Tang", "person_email": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; safia.tang@novartis.com; software.demand@novartis.com; michael.noethiger@novartis.com", "internal_name": "Jeff Roy; Ross Proudfoot", "internal_email": "jeff@biorender.com; ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d3b079009bb771ade59335cf1ed05b13836776750acd04412043eb004d07024a", "call_id": "2023-05-03_d3b079009bb7", "call_count": 1, "all_snippets": [{"quote": "Now, at the moment, it comes to me, I'm running a call of the demand qualification service where I collect all the software requirements.", "date": "2023-05-03", "callId": "2023-05-03_d3b079009bb7", "gongUrl": "https://app.gong.io/call?id=d3b079009bb771ade59335cf1ed05b13836776750acd04412043eb004d07024a", "speakerId": "3088300652259996757", "customerName": "Adam Tomaszewski; Adam Tomaszewski; Linda Chin; Safia Tang", "internalName": "Jeff Roy; Ross Proudfoot", "customerEmail": "adam.tomaszewski@novartis.com; adam.tomaszewski@novartis.com; linda.chin@novartis.com; safia.tang@novartis.com; software.demand@novartis.com; michael.noethiger@novartis.com", "internalEmail": "jeff@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_novartis_research_institute_35a51462", "company": "novartis", "gong_entity": "Novartis Research Institute", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "is one of the platform of never the research institute in novartis", "snippet_date": "2023-03-24", "person_name": "Francesca Rucci; Vanessa Cornacchione", "person_email": "francesca.rucci@novartis.com; vanessa.cornacchione@novartis.com", "internal_name": "Julia Coupland; Ross Proudfoot", "internal_email": "julia@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "novartis-rd", "manual_node_name": "Novartis Research & Development", "manual_node_path": "Novartis Research & Development", "confidence": "medium", "reasoning": "Likely refers to the overall Novartis Research & Development organization, though the exact naming differs slightly"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=58030a251dad973bd8ec4d9536d4b3ec0635d48e7dc59049f1ada7ed9d7c72bd", "call_id": "2023-03-24_58030a251dad", "call_count": 1, "all_snippets": [{"quote": "is one of the platform of never the research institute in novartis", "date": "2023-03-24", "callId": "2023-03-24_58030a251dad", "gongUrl": "https://app.gong.io/call?id=58030a251dad973bd8ec4d9536d4b3ec0635d48e7dc59049f1ada7ed9d7c72bd", "speakerId": "5888632718747090059", "customerName": "Francesca Rucci; Vanessa Cornacchione", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "francesca.rucci@novartis.com; vanessa.cornacchione@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_novartis_biologics_centre_11aba81b", "company": "novartis", "gong_entity": "Novartis Biologics Centre", "gong_parent": "Novartis Research Institute", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we are both working in novartis biologiccentre. So, is one of the platform of never the research institute in novartis. And we are the all biologica around maybe three hundredish people or something.", "snippet_date": "2023-03-24", "person_name": "Francesca Rucci; Vanessa Cornacchione", "person_email": "francesca.rucci@novartis.com; vanessa.cornacchione@novartis.com", "internal_name": "Julia Coupland; Ross Proudfoot", "internal_email": "julia@biorender.com; ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development", "manual_node_name": "Biologics Development", "manual_node_path": "Novartis Research & Development > Pharmaceutical Sciences (Technical R&D) > Biologics Development", "confidence": "medium", "reasoning": "Strong semantic match - entity mentions 'biologics centre' with ~300 people, which aligns with the Biologics Development department focused on biological drug development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=58030a251dad973bd8ec4d9536d4b3ec0635d48e7dc59049f1ada7ed9d7c72bd", "call_id": "2023-03-24_58030a251dad", "call_count": 1, "all_snippets": [{"quote": "we are both working in novartis biologiccentre. So, is one of the platform of never the research institute in novartis. And we are the all biologica around maybe three hundredish people or something.", "date": "2023-03-24", "callId": "2023-03-24_58030a251dad", "gongUrl": "https://app.gong.io/call?id=58030a251dad973bd8ec4d9536d4b3ec0635d48e7dc59049f1ada7ed9d7c72bd", "speakerId": "5888632718747090059", "customerName": "Francesca Rucci; Vanessa Cornacchione", "internalName": "Julia Coupland; Ross Proudfoot", "customerEmail": "francesca.rucci@novartis.com; vanessa.cornacchione@novartis.com", "internalEmail": "julia@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_novartis_institute_for_medical_research_1dab06c6", "company": "novartis", "gong_entity": "Novartis Institute for Medical Research", "gong_parent": "Novartis R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "There's never, Novartis is for medical research, everything from the idea to phase one two trials.", "snippet_date": "2023-03-08", "person_name": "Giorgio Galli", "person_email": "giorgio.galli@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": {"manual_node_id": "biomedical-research", "manual_node_name": "Biomedical Research", "manual_node_path": "Novartis Research & Development > Biomedical Research", "confidence": "medium", "reasoning": "Good semantic match - entity describes research 'from idea to phase one two trials' which aligns with the Biomedical Research division's scope of early-stage research"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4d82507532e3f1bbf04f0de7817f743a01250363d71fd78929db3a7c7d261fcb", "call_id": "2023-03-08_4d82507532e3", "call_count": 1, "all_snippets": [{"quote": "There's never, Novartis is for medical research, everything from the idea to phase one two trials.", "date": "2023-03-08", "callId": "2023-03-08_4d82507532e3", "gongUrl": "https://app.gong.io/call?id=4d82507532e3f1bbf04f0de7817f743a01250363d71fd78929db3a7c7d261fcb", "speakerId": "6195974905364944850", "customerName": "Giorgio Galli", "internalName": "Ross Proudfoot", "customerEmail": "giorgio.galli@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": []}]}, {"id": "novartis_biology_a46229cf", "company": "novartis", "gong_entity": "Biology", "gong_parent": "Novartis R&D", "entity_type": "department", "team_size": "14", "confidence": "medium", "mention_count": 1, "snippet": "So I'm part of biology. So I have a group of around 14 people.", "snippet_date": "2023-03-08", "person_name": "Giorgio Galli", "person_email": "giorgio.galli@novartis.com", "internal_name": "Ross Proudfoot", "internal_email": "ross@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=4d82507532e3f1bbf04f0de7817f743a01250363d71fd78929db3a7c7d261fcb", "call_id": "2023-03-08_4d82507532e3", "call_count": 1, "all_snippets": [{"quote": "So I'm part of biology. So I have a group of around 14 people.", "date": "2023-03-08", "callId": "2023-03-08_4d82507532e3", "gongUrl": "https://app.gong.io/call?id=4d82507532e3f1bbf04f0de7817f743a01250363d71fd78929db3a7c7d261fcb", "speakerId": "6195974905364944850", "customerName": "Giorgio Galli", "internalName": "Ross Proudfoot", "customerEmail": "giorgio.galli@novartis.com", "internalEmail": "ross@biorender.com", "sizeMentions": [{"value": "14", "snippetIndex": 0, "source": {"callDate": "2023-03-08", "customerName": "Giorgio Galli"}}]}]}]}